Universität zu Köln

Journal Article

Aldin, Angela, Umlauff, Lisa, Estcourt, Lise J., Collins, Gary ORCID: 0000-0002-2772-2316, Moons, Karel G. M., Engert, Andreas, Kobe, Carsten, von Tresckow, Bastian, Haque, Madhuri, Foroutan, Farid, Kreuzberger, Nina, Trivella, Marialena ORCID: 0000-0003-4492-1760 and Skoetz, Nicole (2019). Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies. Cochrane Database Syst Rev. (9). HOBOKEN: WILEY. ISSN 1361-6137

Aldin, Angela, Umlauff, Lisa, Estcourt, Lise J., Collins, Gary, Moons, Karel G. M., Engert, Andreas, Kobe, Carsten, von Tresckow, Bastian, Haque, Madhuri, Foroutan, Farid, Kreuzberger, Nina ORCID: 0000-0001-8922-0488, Trivella, Marialena and Skoetz, Nicole (2020). Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies. Cochrane Database Syst Rev. (1). HOBOKEN: WILEY. ISSN 1361-6137

Armand, Philippe, Engert, Andreas, Younes, Anas, Fanale, Michelle, Santoro, Armando ORCID: 0000-0003-1709-9492, Zinzani, Pier Luigi, Timmerman, John M., Collins, Graham P., Ramchandren, Radhakrishnan, Cohen, Jonathon B., De Boer, Jan Paul, Kuruvilla, John, Savage, Kerry J., Trneny, Marek, Shipp, Margaret A., Kato, Kazunobu, Sumbul, Anne, Farsaci, Benedetto ORCID: 0000-0001-8275-2561 and Ansell, Stephen M. (2018). Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial. J. Clin. Oncol., 36 (14). S. 1428 - 1450. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Armand, Philippe, Engert, Andreas, Younes, Anas, Lee, Hun Ju, Santoro, Armando, Zinzani, Pier Luigi, Timmerman, John M., Collins, Graham P., Ramchandren, Radhakrishnan, Cohen, Jonathon B., De Boer, Jan Paul, Savage, Kerry J., Kuruvilla, John, Trneny, Marek, Shipp, Margaret A., Sacchi, Mariana, Ansell, Anne Sumbuland Stephen M. and Ansell, Stephen M. (2018). Nivolumab for Relapsed or Refractory Classical Hodgkin Lymphoma (cHL) after Autologous Hematopoietic Cell Transplantation (auto-HCT): Extended Follow-up of the Phase 2 Single-Arm CheckMate 205 Study. Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Bandapalli, Obul Reddy ORCID: 0000-0002-1132-1745, Paramasivam, Nagarajan, Giangiobbe, Sara, Kumar, Abhishek, Benisch, Wolfgang, Engert, Andreas, Witzens-Harig, Mathias, Schlesner, Mathias, Hemminki, Kari and Foersti, Asta (2018). Whole genome sequencing reveals DICER1 as a candidate predisposing gene in familial Hodgkin lymphoma. Int. J. Cancer, 143 (8). S. 2076 - 2079. HOBOKEN: WILEY. ISSN 1097-0215

Bauer, Kathrin, Rancea, Michaela, Schmidtke, Bettina, Kluge, Sabine, Monsef, Ina, Huebel, Kai, Engert, Andreas and Skoetz, Nicole ORCID: 0000-0003-4744-6192 (2011). Thirteenth Biannual Report of the Cochrane Haematological Malignancies Group-Focus on Multiple Myeloma. JNCI-J. Natl. Cancer Inst., 103 (17). S. E1 - 19. CARY: OXFORD UNIV PRESS INC. ISSN 1460-2105

Baues, Christian, Goergen, Helen, Fuchs, Michael, Rosenbrock, Johannes, Celik, Eren, Eich, Hans, Kobe, Carsten, Voltin, Conrad-Amadeus, Engert, Andreas, Borchmann, Peter and Marnitz, Simone (2021). Involved-Field Radiation Therapy Prevents Recurrences in the Early Stages of Hodgkin Lymphoma in PET-Negative Patients After ABVD Chemotherapy: Relapse Analysis of GHSG Phase 3 HD16 Trial. Int. J. Radiat. Oncol. Biol. Phys., 111 (4). S. 900 - 907. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1879-355X

Baues, Christian, Goergen, Helen, Semrau, Robert, Nast-Kolb, Beatrix, Assenmacher, Katja, Celik, Eren, Morgenthaler, Janis, Rosenbrock, Johannes, Trommer-Nestler, Maike, Houbois, Christian, Kobe, Carsten, Kriz, Jan, Engert, Andreas and Marnitz, Simone (2019). Volumetric assessment of mediastinal lymphoma masses in Hodgkin lymphoma. Leuk. Lymphoma, 60 (13). S. 3244 - 3251. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Baues, Christian, Marnitz, Simone, Engert, Andreas, Baus, Wolfgang, Jablonska, Karolina, Fogliata, Antonella ORCID: 0000-0002-2282-9894, Vasquez-Torres, Andres, Scorsetti, Marta and Cozzi, Luca (2018). Proton versus photon deep inspiration breath hold technique in patients with hodgkin lymphoma and mediastinal radiation A PLANNING COMPARISON OF DEEP INSPIRATION BREATH HOLD INTENSITY MODULATION RADIOTHERAPY AND INTENSITY MODULATED PROTON THERAPY. Radiat. Oncol., 13. LONDON: BMC. ISSN 1748-717X

Baues, Christian, Trommer-Nestler, Maike, Jablonska, Karolina, Broeckelmann, Paul J., Schlaak, Max, von Bergwelt-Baildon, Michael, Engert, Andreas, Semrau, Robert, Marnitz, Simone and Theurich, Sebastian ORCID: 0000-0001-5706-8258 (2017). Short review of potential synergies of immune checkpoint inhibition and radiotherapy with a focus on Hodgkin lymphoma: radio-immunotherapy opens new doors. Immunotherapy, 9 (5). S. 423 - 434. LONDON: FUTURE MEDICINE LTD. ISSN 1750-7448

Behringer, Karolin, Goergen, Helen, Mueller, Horst, Thielen, Indra, Brillant, Corinne, Kreissl, Stefanie, Halbsguth, Teresa Veronika, Meissner, Julia, Greil, Richard, Moosmann, Peter, Shonukan, Oluwatoyin, Rueffer, Jens Ulrich, Flechtner, Hans-Henning, Fuchs, Michael, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2016). Cancer-Related Fatigue in Patients With and Survivors of Hodgkin Lymphoma: The Impact on Treatment Outcome and Social Reintegration. J. Clin. Oncol., 34 (36). S. 4329 - 4346. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Behringer, Karolin, Thielen, Indra, Mueller, Horst, Goergen, Helen, Eibl, Angelika, Rosenbrock, Johannes, Halbsguth, Teresa, Reiners, Katrin S., Diehl, Volker, Engert, Andreas and Borchmann, Peter (2011). Fertility and Gonadal Function After Treatment of Early Unfavorable Hodgkin Lymphoma (HL): An Analysis of the German Hodgkin Study Group (GHSG). Blood, 118 (21). S. 199 - 200. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Bergenthal, Nils, Will, Andrea, Streckmann, Fiona, Wolkewitz, Klaus-Dieter, Monsef, Ina, Engert, Andreas, Elter, Thomas and Skoetz, Nicole (2014). Aerobic physical exercise for adult patients with haematological malignancies. Cochrane Database Syst Rev. (11). HOBOKEN: WILEY. ISSN 1361-6137

Blank, Oliver, von Tresckow, Bastian, Monsef, Ina, Specht, Lena ORCID: 0000-0002-6902-2190, Engert, Andreas and Skoetz, Nicole (2017). Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphoma. Cochrane Database Syst Rev. (4). HOBOKEN: WILEY. ISSN 1361-6137

Boell, Boris, Behringer, Karolin, Goergen, Helen, Broeckelmann, Paul, von Tresckow, Bastian, Eichenauer, Dennis A., Fuchs, Michael, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2014). Doxorubicin, Vinblastine and Dacarbazine with or without Bleomycin for Older Patients with Early Stage Favorable Hodgkin Lymphoma: An Analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 Trials. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Boell, Boris, Bredenfeld, Henning, Goergen, Helen, Halbsguth, Teresa, Eich, Hans T., Soekler, Martin, Markova, Jana, Keller, Ulrich, Graeven, Ullrich, Kremers, Stephan, Geissler, Michael, Trenn, Guido, Fuchs, Michael, von Tresckow, Bastian, Eichenauer, Dennis A., Borchmann, Peter and Engert, Andreas (2011). Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma. Blood, 118 (24). S. 6292 - 6299. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Boell, Boris, Fossa, Alexander, Goergen, Helen, Kamper, Peter, Leppa, Sirpa, Molin, Daniel, Meissner, Julia, Ritter, Ellen, Christensen, Jacob H., Hutchings, Martin ORCID: 0000-0003-3873-1741, Fuchs, Michael, Engert, Andreas, Kobe, Carsten and Borchmann, Peter (2018). B-CAP (brentuximab vedotin, cyclophosphamide, doxorubicin and predniso(lo)Ne) in Older Patients with Advanced-Stage Hodgkin Lymphoma: Results of a Phase II Intergroup Trial By the German Hodgkin Study Group (GHSG) and the Nordic Lymphoma Group (NLG). Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Boell, Boris, Goergen, Helen, Arndt, Nils, Meissner, Julia, Krause, Stefan W., Schnell, Roland, von Tresckow, Bastian, Eichenauer, Dennis A., Sasse, Stephanie, Fuchs, Michael, Behringer, Karalin, Klimm, Beate C., Naumann, Ralph, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2013). Relapsed Hodgkin Lymphoma in Older Patients: A Comprehensive Analysis From the German Hodgkin Study Group. J. Clin. Oncol., 31 (35). S. 4431 - 4442. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Boell, Boris, Goergen, Helen, Behringer, Karolin, Broeckelmann, Paul J., Hitz, Felicitas, Kerkhoff, Andrea, Greil, Richard, von Tresckow, Bastian, Eichenauer, Dennis A., Buerkle, Carolin, Borchmann, Sven, Fuchs, Michael, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2016). Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials. Blood, 127 (18). S. 2189 - 2193. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Boell, Boris, Pluetschow, Annette, Buerkle, Carolin, Atta, Johannes, Pfreundschuh, Michael, Feuring-Buske, Michaela, Vogelhuber, Martin, Soekler, Martin, Eichenauer, Dennis A., Thielen, Indra, von Tresckow, Bastian, Fuchs, Michael, Engert, Andreas and Borchmann, Peter (2019). Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase-I trial. Br. J. Haematol., 185 (1). S. 42 - 53. HOBOKEN: WILEY. ISSN 1365-2141

Bokemeyer, Carsten, Engert, Andreas, Goekbuget, Nadja and Schmutzler, Rita (2019). Targeted Early Detection and risk-adapted Therapy. Oncol. Res. Treat., 42. S. 2 - 14. BASEL: KARGER. ISSN 2296-5262

Boll, Boris, Gorgen, Helen, Fuchs, Michael, von Tresckow, Bastian, Engert, Andreas and Borchmann, Peter (2010). Feasibility and Efficacy of ABVD In Elderly Hodgkin Lymphoma Patients: Analysis of Two Randomized Prospective Multicenter Trials of the German Hodgkin Study Group (HD10 and HD11). Blood, 116 (21). S. 186 - 188. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Borchmann, Peter, Eichenauer, Dennis A., Pluetschow, Annette, Haverkamp, Heinz, Kreissl, Stefanie, Fuchs, Michael, Soekler, Martin, Hellmuth, Johannes C., Meissner, Julia, Mathas, Stephan, Behringer, Karolin, Dietlein, Markus, Kobe, Carsten, Diehl, Volker and Engert, Andreas (2015). Targeted Beacopp Variants in Patients with Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma: Final Analysis of a Randomized Phase II Study. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Borchmann, Peter and Engert, Andreas (2016). Balancing the Risk-Benefit Ratio in the Treatment of Patients With Advanced-Stage Hodgkin Lymphoma. J. Clin. Oncol., 34 (17). S. 1975 - 1979. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Borchmann, Peter and Engert, Andreas (2017). How Relevant Is Treatment-Related Infertility for Individual Treatment Selection in Hodgkin Lymphoma? Reply. J. Clin. Oncol., 35 (3). S. 375 - 378. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Borchmann, Peter and Engert, Andreas (2010). The Past: What We Have Learned in the Last Decade. Hematol.-Am. Soc. Hematol. Educ. Program. S. 101 - 108. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1520-4383

Borchmann, Peter, Engert, Andreas and Diehl, Volker (2011). CHEMOTHERAPY Hodgkin lymphoma-absence of evidence not evidence of absence! Nat. Rev. Clin. Oncol., 8 (11). S. 636 - 639. NEW YORK: NATURE PUBLISHING GROUP. ISSN 1759-4774

Borchmann, Peter, Goergen, Helen, Kobe, Carsten, Lohri, Andreas, Greil, Richard, Eichenauer, Dennis A., Zijlstra, Josee M., Markova, Jana, Meissner, Julia, Feuring-Buske, Michaela, Huttmann, Andreas ORCID: 0000-0003-2230-3873, Dierlamm, Judith, Soekler, Martin, Beck, Hans-Joachim, Willenbacher, Wolfgang, Ludwig, Wolf-Dieter, Pabst, Thomas, Topp, Max S., Hitz, Felicitas, Bentz, Martin, Keller, Ulrich Bernd, Kuhnhardt, Dagmar, Ostermann, Helmut, Schmitz, Norbert, Hertenstein, Bernd, Aulitzky, Walter, Maschmeyer, Georg, Vieler, Tom, Eich, Hans, Baues, Christian, Stein, Harald, Fuchs, Michael, Kuhnert, Georg, Diehl, Volker, Dietlein, Markus and Engert, Andreas (2017). PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group. Lancet, 390 (10114). S. 2790 - 2803. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-547X

Borchmann, Peter, Haverkamp, Heinz ORCID: 0000-0001-6895-4132, Diehl, Volker, Cerny, Thomas, Markova, Jana, Ho, Anthony D., Eich, Hans-Theodor, Mueller-Hermelink, Hans Konrad, Kanz, Lothar, Greil, Richard, Rank, Andreas, Paulus, Ursula, Smardova, Lenka, Huber, Christoph, Doerken, Bernd, Nerl, Christoph, Krause, Stefan W., Mueller, Rolf-Peter, Fuchs, Michael and Engert, Andreas (2011). Eight Cycles of Escalated-Dose BEACOPP Compared With Four Cycles of Escalated-Dose BEACOPP Followed by Four Cycles of Baseline-Dose BEACOPP With or Without Radiotherapy in Patients With Advanced-Stage Hodgkin's Lymphoma: Final Analysis of the HD12 Trial of the German Hodgkin Study Group. J. Clin. Oncol., 29 (32). S. 4234 - 4243. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 0732-183X

Borchmann, Peter, Haverkamp, Heinz, Lohri, Andreas, Kreissl, Stefanie, Greil, Richard, Markova, Jana, Feuring-Buske, Michaela, Meissner, Julia, Duehrsen, Ulrich, Engel, Nicole, Keller, Ulrich, Maschmeyer, Georg, Dietlein, Markus, Kobe, Carsten, Fuchs, Michael, Diehl, Volker and Engert, Andreas (2014). Addition of Rituximab to BEACOPP(escalated) to Improve the Outcome of Early Interim PET Positive Advanced Stage Hodgkin Lymphoma Patients: Second Planned Interim Analysis of the HD18 Study. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Borchmann, Peter, Haverkamp, Heinz ORCID: 0000-0001-6895-4132, Lohri, Andreas, Mey, Ulrich, Kreissl, Stefanie, Greil, Richard, Markova, Jana, Feuring-Buske, Michaela, Meissner, Julia, Duehrsen, Ulrich, Ostermann, Helmut, Keller, Ulrich, Maschmeyer, Georg, Kuhnert, Georg, Dietlein, Markus, Kobe, Carsten, Eich, Hans, Baues, Christian, Stein, Harald, Fuchs, Michael, Diehl, Volker and Engert, Andreas (2017). Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP(escalated) alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group. Lancet Oncol., 18 (4). S. 454 - 464. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488

Borchmann, Peter, Moccia, Alden, Greil, Richard, Hertzberg, Mark, Schaub, Valdete, Huettmann, Andreas, Keil, Felix, Dierlamm, Judith, Haenel, Mathias, Novak, Urban, Meissner, Julia, Zimmermann, Andreas, Mathas, Stephan, Zijlstra, Josee M., Fossa, Alexander, Viardot, Andreas, Hertenstein, Bernd, Martin, Sonja, Giri, Pratyush, Kamper, Peter, Molin, Daniel, Kreissl, Stefanie, Fuchs, Michael, Schneider, Gundolf, Rosenwald, Andreas, Klapper, Wolfram, Eich, Hans, Baues, Christian, Hallek, Michael, Dietlein, Markus, Kobe, Carsten, Diehl, Volker and Engert, Andreas (2022). Treatment Related Morbidity in Patients with Classical Hodgkin Lymphoma: Results of the Ongoing, Randomized Phase III HD21 Trial By the German Hodgkin Study Group. Blood, 140. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Borchmann, Sven, Cirillo, Melita, Goergen, Helen, Meder, Lydia ORCID: 0000-0002-9547-5812, Sasse, Stephanie, Kreissl, Stefanie, Broeckelmann, Paul Jan, von Tresckow, Bastian, Fuchs, Michael, Ullrich, Roland Tillmann and Engert, Andreas (2019). Pretreatment Vitamin D Deficiency Is Associated With Impaired Progression-Free and Overall Survival in Hodgkin Lymphoma. J. Clin. Oncol., 37 (36). S. 3528 - 3539. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Borchmann, Sven and Engert, Andreas (2017). The genetics of Hodgkin lymphoma: an overview and clinical implications. Curr. Opin. Oncol., 29 (5). S. 307 - 315. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1531-703X

Borchmann, Sven, Engert, Andreas and Boell, Boris (2018). Hodgkin lymphoma in elderly patients. Curr. Opin. Oncol., 30 (5). S. 308 - 317. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1531-703X

Borchmann, Sven, Hude, Ida, Muller, Horst, Haverkamp, Heinz, Burkle, Carolin, Fuchs, Michael, Borchmann, Peter and Engert, Andreas (2016). Thrombosis in Hodgkin Lymphoma Patients: Incidence, Time Points, Risk Factors and Impact of Stage and Treatment. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Borchmann, Sven, Mueller, Horst and Engert, Andreas (2017). Hodgkin Lymphoma has a seasonal pattern of incidence and mortality that depends on latitude. Sci Rep, 7. LONDON: NATURE PUBLISHING GROUP. ISSN 2045-2322

Borchmann, Sven, Mueller, Horst and Engert, Andreas (2016). Seasonal Differences in Incidence and Survival of Hodgkin Lymphoma Depend on Geographic Location of Diagnosis. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Borchmann, Sven, Mueller, Horst, Haverkamp, Heinz ORCID: 0000-0001-6895-4132, Baues, Christian, Markova, Jana, Huettmann, Andreas, Glunz, Axel, Fuchs, Michael, Borchmann, Peter and Engert, Andreas (2019). Symptomatic osteonecrosis as a treatment complication in Hodgkin lymphoma: an analysis of the German Hodgkin Study Group (GHSG). Leukemia, 33 (2). S. 439 - 447. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551

Borchmann, Sven, von Tresckow, Bastian and Engert, Andreas (2016). Current developments in the treatment of early-stage classical Hodgkin lymphoma. Curr. Opin. Oncol., 28 (5). S. 377 - 384. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1531-703X

Brockelmann, Paul J., Muller, Horst, Guhl, Teresa, Behringer, Karolin, Fuchs, Michael ORCID: 0000-0003-3289-3272, Moccia, Alden A., Rank, Andreas, Soekler, Martin, Vieler, Tom, Pabst, Thomas, Baues, Christian, von Tresckow, Bastian, Borchmann, Peter and Engert, Andreas (2021). Relapse After Early-Stage, Favorable Hodgkin Lymphoma: Disease Characteristics and Outcomes With Conventional or High-Dose Chemotherapy. J. Clin. Oncol., 39 (2). S. 107 - 122. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1527-7755

Brockelmann, Paul J., von Tresckow, Bastian and Engert, Andreas (2022). Novel therapeutic approaches in relapsed or refractory Hodgkin lymphoma. Onkologie, 28 (10). S. 901 - 908. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 2731-7234

Broeckelmann, Paul J., Borchmann, Peter and Engert, Andreas (2016). Current and future immunotherapeutic approaches in Hodgkin lymphoma. Leuk. Lymphoma, 57 (9). S. 2014 - 2025. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Broeckelmann, Paul J., Borchmann, Sven, Borchmann, Peter and Engert, Andreas (2020). Steering Chimeric Antigen Receptor T Cells Into the Hodgkin Lymphoma Niche. J. Clin. Oncol., 38 (32). S. 3816 - 3820. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Broeckelmann, Paul J., Buehnen, Ina, Meissner, Julia, Trautmann-Grill, Karolin, Herhaus, Peter, Halbsguth, Teresa, V, Schaub, Valdete, Kerkhoff, Andrea, Mathas, Stephan, Bormann, Matthias, Dickhut, Andreas, Kaul, Helen, Fuchs, Michael, Kobe, Carsten, Baues, Christian, Borchmann, Peter, Engert, Andreas and von Tresckow, Bastian (2022). Nivolumab and AVD in Early-Stage Unfavorable Hodgkin Lymphoma: Follow-up Analysis of the Randomized GHSG Phase II Nivahl Trial. Blood, 140. S. 1753 - 1756. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Broeckelmann, Paul J., Eichenauer, Dennis A., Jakob, Tina, Follmann, Markus ORCID: 0000-0003-3790-5578, Engert, Andreas and Skoetz, Nicole (2018). Hodgkin Lymphoma in Adults. Dtsch. Arztebl. Int., 115 (31-32). S. 535 - 546. COLOGNE: DEUTSCHER AERZTE-VERLAG GMBH. ISSN 1866-0452

Broeckelmann, Paul J. and Engert, Andreas (2017). Checkpoint Inhibition in Hodgkin Lymphoma - a Review. Oncol. Res. Treat., 40 (11). S. 654 - 660. BASEL: KARGER. ISSN 2296-5262

Broeckelmann, Paul J. and Engert, Andreas (2015). The GHSG Approach to Treating Hodgkin's Lymphoma. Curr. Hematol. Malig. Rep., 10 (3). S. 256 - 266. PHILADELPHIA: CURRENT MEDICINE GROUP. ISSN 1558-822X

Broeckelmann, Paul J., Goergen, Helen, Fuchs, Michael, Kriz, Jan, Semrau, Robert, Baues, Christian, Kobe, Carsten, Behringer, Karolin, Eichenauer, Dennis A., von Tresckow, Bastian, Klimm, Beate, Halbsguth, Teresa, Wongso, Diana, Pluetschow, Annette, Haverkamp, Heinz ORCID: 0000-0001-6895-4132, Dietlein, Markus, Eich, Hans T., Stein, Harald, Diehl, Volker, Borchmann, Peter and Engert, Andreas (2015). Impact of centralized diagnostic review on quality of initial staging in Hodgkin lymphoma: experience of the German Hodgkin Study Group. Br. J. Haematol., 171 (4). S. 547 - 557. HOBOKEN: WILEY. ISSN 1365-2141

Broeckelmann, Paul J., Goergen, Helen, Keller, Ulrich, Meissner, Julia, Ordemann, Rainer, Halbsguth, Teresa V., Sasse, Stephanie, Soekler, Martin, Kerkhoff, Andrea, Mathas, Stephan, Huettmann, Andreas, Bormann, Matthias, Zimmermann, Andreas, Mettler, Jasmin, Fuchs, Michael, von Tresckow, Bastian, Baues, Christian, Rosenwald, Andreas, Klapper, Wolfram, Kobe, Carsten, Borchmann, Peter and Engert, Andreas (2020). Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial. JAMA Oncol., 6 (6). S. 872 - 881. CHICAGO: AMER MEDICAL ASSOC. ISSN 2374-2445

Broeckelmann, Paul J., Goergen, Helen, Kohnhorst, Charlotte, Von Tresckow, Bastian, Moccia, Alden, Markova, Jana, Meissner, Julia, Kerkhoff, Andrea, Ludwig, Wolf-Dieter, Fuchs, Michael, Borchmann, Peter and Engert, Andreas (2017). Late Relapse of Classical Hodgkin Lymphoma: An Analysis of the German Hodgkin Study Group HD7 to HD12 Trials. J. Clin. Oncol., 35 (13). S. 1444 - 1455. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Broeckelmann, Paul J., Mueller, Horst, Casasnovas, Olivier, Hutchings, Martin ORCID: 0000-0003-3873-1741, von Tresckow, Bastian, Borchmann, Peter, Moskowitz, Craig and Engert, Andreas (2015). Risk Factors and a Prognostic Score for Progression Free Survival after Treatment with Autologous Stem Cell Transplantation (ASCT) in Patients with Relapsed or Refractory Hodgkin Lymphoma (rrHL). Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Broeckelmann, Paul J., Mueller, Horst, Gillessen, Sarah, Yang, Xiaoqin, Koeppel, Larissa, Pilz, Veronika, Marinello, Patricia, Kaskel, Peter, Raut, Monika, Fuchs, Michael, Borchmann, Peter, Engert, Andreas and von Tresckow, Bastian (2022). Clinical outcomes of relapsed and refractory Hodgkin lymphoma patients after contemporary first-line treatment: a German Hodgkin Study Group analysis. Leukemia, 36 (3). S. 772 - 781. LONDON: SPRINGERNATURE. ISSN 1476-5551

Broeckelmann, Paul J., Sasse, Stephanie and Engert, Andreas (2018). Balancing risk and benefit in early-stage classical Hodgkin lymphoma. Blood, 131 (15). S. 1666 - 1679. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Broeckelmann, Paul J., von Tresckow, Bastian and Engert, Andreas (2018). Relapsed or refractory classical Hodgkin's lymphoma. Novel therapeutic approaches. Onkologe, 24 (4). S. 322 - 329. NEW YORK: SPRINGER. ISSN 1433-0415

Cheah, Chan Y., Broeckelmann, Paul J., Chihara, Dai ORCID: 0000-0002-1153-2294, Moskowitz, Alison J., Engert, Andreas, Jerkeman, Mats, El-Galaly, Tarec C., Augustson, Bradley, Vose, Julie, Bartlett, Nancy L., Villa, Diego, Connors, Joseph M., Feldman, Tatyana, Pinnix, Chelsea C., Milgrom, Sarah A., Dabaja, Bouthaina, Oki, Yasuhiro and Fanale, Michelle A. (2016). Clinical characteristics and outcomes of patients with Hodgkin lymphoma with central nervous system involvement: An international multicenter collaboration. Am. J. Hematol., 91 (9). S. 894 - 900. HOBOKEN: WILEY. ISSN 1096-8652

Cheah, Chan Yoon, Broeckelmann, Paul J., Moskowitz, Alison J., Engert, Andreas, Jerkeman, Mats, El-Galaly, Tarec Christoffer, Vose, Julie, Villa, Diego, Connors, Joseph M., Feldman, Tatyana, Chihara, Dai, Pinnix, Chelsea C., Milgrom, Sarah A., Dabaja, Bouthaina S., Oki, Yasuhiro and Fanale, Michelle A. (2015). Clinical Characteristics and Outcomes of Patients with Hodgkin Lymphoma with Central Nervous System Involvement: An International Multicenter Collaboration. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Chen, Robert, Gopal, Ajay K., Smith, Scott E., Ansell, Stephen, Rosenblatt, Joseph D., Savage, Kerry J., Connors, Joseph M., Engert, Andreas, Larsen, Emily K., Huebner, Dirk, Fong, Abraham and Younes, Anas (2015). Five-Year Survival Data Demonstrating Durable Responses from a Pivotal Phase 2 Study of Brentuximab Vedotin in Patients with Relapsed or Refractory Hodgkin Lymphoma. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Chen, Robert, Gopal, Ajay K., Smith, Scott E., Ansell, Stephen M., Rosenblatt, Joseph D., Savage, Kerry J., Connors, Joseph M., Engert, Andreas, Larsen, Emily K., Huebner, Dirk, Fong, Abraham and Younes, Anas (2016). Five-year survival and durability results of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma. Blood, 128 (12). S. 1562 - 1567. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Chen, Robert W., Gopal, Ajay K., Smith, Scott E., Ansell, Stephen M., Rosenblatt, Joseph D., Savage, Kerry J., Connors, Joseph M., Engert, Andreas, Larsen, Emily K., Sievers, Eric L. and Younes, Anas (2012). Long-Term Survival Analyses of an Ongoing Phase 2 Study of Brentuximab Vedotin in Patients with Relapsed or Refractory Hodgkin Lymphoma. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Cohen, Jonathon B., Kuruvilla, John, Engert, Andreas, Ansell, Stephen M., Younes, Anas, Lee, Hun Ju, Trneny, Marek, Savage, Kerry J., Ramchandren, Radhakrishnan, Collins, Graham P., Zinzani, Pier Luigi, De Boer, Jan Paul, Shipp, Margaret A., Santoro, Armando, Timmerman, John M., Sacchi, Mariana, Sy, Oumar and Armand, Philippe (2018). Nivolumab Treatment Beyond Investigator-Assessed Progression: Extended Follow-up in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma from the Phase 2 CheckMate 205 Study. Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Cools, Jan ORCID: 0000-0001-6626-5843 and Engert, Andreas (2021). The Fifth Year of HemaSphere. Hemasphere, 5 (6). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 2572-9241

Coutelle, Oliver, Buening, Hildegard, Pluetschow, Annette, Fuchs, Michael, Escalona-Espinosa, Laura, Engert, Andreas and Hacker, Ulrich ORCID: 0000-0002-3253-8206 (2014). Prognostic Serum Cytokines in Classical Hodgkin Lymphoma-Letter. Clin. Cancer Res., 20 (24). S. 6633 - 6634. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1557-3265

Damaschin, Carla, Goergen, Helen, Kreissl, Stefanie, Pluetschow, Annette, Breywisch, Frank, Mathas, Stephan, Meissner, Julia, Soekler, Martin, Topp, Max S., Vucinic, Vladan, Zimmermann, Andreas, von Tresckow, Bastian, Fuchs, Michael, Engert, Andreas, Borchmann, Peter and Eichenauer, Dennis A. (2022). Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma: follow-up analysis of a randomized phase II study from the German Hodgkin Study Group. Leukemia, 36 (2). S. 580 - 583. LONDON: SPRINGERNATURE. ISSN 1476-5551

Doersam, Bastian, Boesl, Teresa, Reiners, Katrin S., Barnert, Sabine, Schubert, Rolf, Shatnyeva, Olga, Zigrino, Paola ORCID: 0000-0002-7470-0064, Engert, Andreas, Hansen, Hinrich P. and von Strandmann, Elke Pogge (2018). Hodgkin Lymphoma-Derived Extracellular Vesicles Change the Secretome of Fibroblasts Toward a CAF Phenotype. Front. Immunol., 9. LAUSANNE: FRONTIERS MEDIA SA. ISSN 1664-3224

Eich, Hans Theodor, Diehl, Volker, Goergen, Helen, Pabst, Thomas, Markova, Jana, Debus, Juergen, Ho, Anthony, Doerken, Bernd, Rank, Andreas, Grosu, Anca-Ligia, Wiegel, Thomas, Karstens, Johann Hinrich, Greil, Richard, Willich, Normann, Schmidberger, Heinz, Doehner, Hartmut, Borchmann, Peter, Mueller-Hermelink, Hans-Konrad, Mueller, Rolf-Peter and Engert, Andreas (2010). Intensified Chemotherapy and Dose-Reduced Involved-Field Radiotherapy in Patients With Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD11 Trial. J. Clin. Oncol., 28 (27). S. 4199 - 4207. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Eichenauer, Dennis A., Becker, Ingrid ORCID: 0000-0001-5829-3553, Monsef, Ina, Chadwick, Nicholas, de Sanctis, Vitaliana, Federico, Massimo, Fortpied, Catherine, Gianni, Alessandro M., Henry-Amar, Michel ORCID: 0000-0002-9357-6476, Hoskin, Peter ORCID: 0000-0001-8323-9567, Johnson, Peter ORCID: 0000-0003-2306-4974, Luminari, Stefano ORCID: 0000-0001-8446-2285, Bellei, Monica ORCID: 0000-0001-7846-732X, Pulsoni, Alessandro, Sydes, Matthew R., Valagussa, Pinuccia, Viviani, Simonetta ORCID: 0000-0002-5014-9546, Engert, Andreas and Franklin, Jeremy ORCID: 0000-0003-1536-0925 (2017). Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: a systematic review and meta-analysis of randomized clinical trials. Haematologica, 102 (10). S. 1748 - 1758. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Eichenauer, Dennis A. ORCID: 0000-0002-1927-3514, Buehnen, Ina, Pluetschow, Annette, Kobe, Carsten, Dietlein, Markus, Wendtner, Clemens-Martin, Thorspecken, Sven, Topp, Max S., Mauser, Mareike, von Tresckow, Bastian, Fuchs, Michael, Borchmann, Peter and Engert, Andreas (2022). Phase II study of fixed-duration single-agent ibrutinib in relapsed nodular lymphocyte-predominant Hodgkin lymphoma: A report from the German Hodgkin Study Group. Hematol. Oncol., 40 (4). S. 801 - 805. HOBOKEN: WILEY. ISSN 1099-1069

Eichenauer, Dennis A. ORCID: 0000-0002-1927-3514, Buhnen, Ina, Kreissl, Stefanie, Goergen, Helen, Fuchs, Michael, von Tresckow, Bastian, Rosenwald, Andreas, Klapper, Wolfram, Hansmann, Martin-Leo, Moller, Peter, Bernd, Heinz-Wolfram, Feller, Alfred C., Engert, Andreas, Borchmann, Peter and Hartmann, Sylvia (2022). Histopathological growth patterns in patients with advanced nodular lymphocyte-predominant Hodgkin lymphoma treated within the randomized HD18 study: a report from the German Hodgkin Study Group. Br. J. Haematol., 196 (1). S. 99 - 105. HOBOKEN: WILEY. ISSN 1365-2141

Eichenauer, Dennis A., Eich, Hans Theodor and Engert, Andreas (2022). Treatment of nodular lymphocyte-predominant Hodgkin lymphoma. Onkologie, 28 (10). S. 908 - 914. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 2731-7234

Eichenauer, Dennis A. and Engert, Andreas (2012). Advances in the treatment of Hodgkin lymphoma. Int. J. Hematol., 96 (5). S. 535 - 544. TOKYO: SPRINGER JAPAN KK. ISSN 1865-3774

Eichenauer, Dennis A. and Engert, Andreas (2014). Antibodies and antibody-drug conjugates in the treatment of Hodgkin lymphoma. Eur. J. Haematol., 93 (1). S. 1 - 9. HOBOKEN: WILEY. ISSN 1600-0609

Eichenauer, Dennis A. and Engert, Andreas (2021). Current treatment options for nodular lymphocyte-predominant Hodgkin lymphoma. Curr. Opin. Oncol., 33 (5). S. 395 - 400. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1531-703X

Eichenauer, Dennis A. ORCID: 0000-0002-1927-3514 and Engert, Andreas (2020). How I treat nodular lymphocyte-predominant Hodgkin lymphoma. Blood, 136 (26). S. 2987 - 2994. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Eichenauer, Dennis A. and Engert, Andreas (2017). Nodular lymphocyte-predominant Hodgkin lymphoma: a unique disease deserving unique management. Hematol.-Am. Soc. Hematol. Educ. Program. S. 324 - 329. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1520-4383

Eichenauer, Dennis A. and Engert, Andreas (2017). R-CHOP in NLPHL: who should receive it? Blood, 130 (4). S. 387 - 392. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Eichenauer, Dennis A. and Engert, Andreas (2015). What Is the Role of Rituximab in Nodular Lymphocyte-Predominant Hodgkin Lymphoma? Acta Haematol., 134 (3). S. 185 - 187. BASEL: KARGER. ISSN 1421-9662

Eichenauer, Dennis A. and Engert, Andreas (2017). The evolving role of targeted drugs in the treatment of Hodgkin lymphoma. Expert Rev. Hematol., 10 (9). S. 775 - 783. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1747-4094

Eichenauer, Dennis A., Fuchs, Michael, Pluetschow, Annette, Klimm, Beate, Halbsguth, Teresa, Boell, Boris, Von Tresckow, Bastian, Nogova, Lucia, Borchmann, Peter and Engert, Andreas (2011). Phase 2 study of rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group. Blood, 118 (16). S. 4363 - 4366. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Eichenauer, Dennis A., Fuchs, Michael, Pluetschow, Annette, Klimm, Beate, Halbsguth, Teresa, Boell, Boris, von Tresckow, Bastian, Borchmann, Peter and Engert, Andreas (2011). Phase II Study of Rituximab in Newly Diagnosed Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): A Report From the German Hodgkin Study Group (GHSG). Blood, 118 (21). S. 1166 - 1168. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Eichenauer, Dennis A., Goergen, Helen, Pluetschow, Annette, Behringer, Karolin, Kreissl, Stefanie, Broeckelmann, Paul, Fuchs, Michael, Boell, Boris, von Tresckow, Bastian, Borchmann, Peter and Engert, Andreas (2015). Phase II Study of Ofatumumab in Relapsed Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Report from the German Hodgkin Study Group. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Eichenauer, Dennis A., Haverkamp, Heinz, Behringer, Karolin, Halbsguth, Teresa, Fuchs, Michael, Diehl, Volker, Borchmann, Peter and Engert, Andreas (2010). Secondary MDS/AML In Hodgkin Lymphoma Patients Treated within German Hodgkin Study Group (GHSG) Clinical Trials After Introduction of the BEACOPP Protocol. Blood, 116 (21). S. 1105 - 1107. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Eichenauer, Dennis A. ORCID: 0000-0002-1927-3514, Muller, Horst, Elger, Leonard, Goergen, Helen, Fuchs, Michael, Kreissl, Stefanie, Boll, Boris, Diehl, Volker, von Tresckow, Bastian, Borchmann, Peter and Engert, Andreas (2021). Non-Hodgkin lymphoma after treatment for classical Hodgkin lymphoma: a report from the German Hodgkin Study Group. Br. J. Haematol., 193 (3). S. 515 - 520. HOBOKEN: WILEY. ISSN 1365-2141

Eichenauer, Dennis A., Pluetschow, Annette, Fuchs, Michael, Behringer, Karolin, Boell, Boris, von Tresckow, Bastian, Diehl, Volker, Borchmann, Peter and Engert, Andreas (2014). Treatment of Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): An Analysis from the German Hodgkin Study Group (GHSG). Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Eichenauer, Dennis A., Pluetschow, Annette, Fuchs, Michael, Hartmann, Sylvia, Hansmann, Martin-Leo, Boell, Boris, von Tresckow, Bastian, Borchmann, Peter and Engert, Andreas (2020). Rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: long-term follow-up of a phase 2 study from the German Hodgkin Study Group. Leukemia, 34 (3). S. 953 - 957. LONDON: SPRINGERNATURE. ISSN 1476-5551

Eichenauer, Dennis A., Pluetschow, Annette, Fuchs, Michael, Sasse, Stephanie, Baues, Christian, Boell, Boris, von Tresckow, Bastian, Diehl, Volker, Borchmann, Peter and Engert, Andreas (2020). Long-Term Follow-Up of Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma Treated in the HD7 to HD15 Trials: A Report From the German Hodgkin Study Group. J. Clin. Oncol., 38 (7). S. 698 - 707. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Eichenauer, Dennis A., Pluetschow, Annette, Fuchs, Michael, von Tresckow, Bastian, Boell, Boris, Behringer, Karolin, Diehl, Volker, Eich, Hans Theodor, Borchmann, Peter and Engert, Andreas (2015). Long-Term Course of Patients With Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the German Hodgkin Study Group. J. Clin. Oncol., 33 (26). S. 2857 - 2865. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Eichenauer, Dennis A., Pluetschow, Annette, Kreissl, Stefanie, Soekler, Martin, Hellmuth, Johannes C. ORCID: 0000-0001-8409-3037, Meissner, Julia, Mathas, Stephan, Topp, Max S., Behringer, Karolin, Klapper, Wolfram, Kuhnert, Georg, Dietlein, Markus, Kobe, Carsten, Fuchs, Michael, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2017). Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group. Lancet Oncol., 18 (12). S. 1680 - 1688. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488

Eichenauer, Dennis A., Pluetschow, Annette, Schroeder, Lena, Fuchs, Michael, Boell, Boris, von Tresckow, Bastian, Diehl, Volker, Borchmann, Peter and Engert, Andreas (2018). Relapsed and refractory nodular lymphocyte-predominant Hodgkin lymphoma: an analysis from the German Hodgkin Study Group. Blood, 132 (14). S. 1519 - 1526. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Eichenauer, Dennis A., Pluetschow, Annette, Schroeder, Lena, Fuchs, Michael, von Tresckow, Bastian, Diehl, Volker, Borchmann, Peter and Engert, Andreas (2016). Relapsed Nodular Lymphocyte-Predominant Hodgkin Lymphoma: An Analysis from the German Hodgkin Study Group (GHSG). Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Eichenauer, Dennis A., Thielen, Indra, Haverkamp, Heinz ORCID: 0000-0001-6895-4132, Franklin, Jeremy ORCID: 0000-0003-1536-0925, Behringer, Karolin, Halbsguth, Teresa, Klimm, Beate, Diehl, Volker, Sasse, Stephanie, Rothe, Achim, Fuchs, Michael, Boell, Boris, von Tresckow, Bastian, Borchmann, Peter and Engert, Andreas (2014). Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group. Blood, 123 (11). S. 1658 - 1665. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Elter, Thomas, Gercheva-Kyuchukova, Liana, Pylylpenko, Halyna, Robak, Tadesuz, Jaksic, Branimir, Rekhtman, Grigoriy, Kyrcz-Krzemien, Slawomira, Vatutin, Mykola, Wu, Jingyang, Sirard, Cynthia, Hallek, Michael and Engert, Andreas (2011). Fludarabine plus alemtuzumab versus fludarabine alone in patients with previously treated chronic lymphocytic leukaemia: a randomised phase 3 trial. Lancet Oncol., 12 (13). S. 1204 - 1214. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488

Enciso-Mora, Victor, Broderick, Peter ORCID: 0000-0002-8348-5829, Ma, Yussanne, Jarrett, Ruth F., Hjalgrim, Henrik, Hemminki, Kari, van den Berg, Anke ORCID: 0000-0002-8894-2638, Olver, Bianca, Lloyd, Amy, Dobbins, Sara E., Lightfoot, Tracy, van Leeuwen, Flora E., Foersti, Asta, Diepstra, Arjan ORCID: 0000-0001-9239-1050, Broeks, Annegien, Vijayakrishnan, Jayaram ORCID: 0000-0002-8284-2249, Shield, Lesley, Lake, Annette, Montgomery, Dorothy, Roman, Eve, Engert, Andreas, von Strandmann, Elke Pogge, Reiners, Katrin S., Nolte, Ilja M., Smedby, Karin E., Adami, Hans-Olov, Russell, Nicola S., Glimelius, Bengt, Hamilton-Dutoit, Stephen ORCID: 0000-0003-2158-3885, de Bruin, Marieke, Ryder, Lars P., Molin, Daniel, Sorensen, Karina Meden, Chang, Ellen T., Taylor, Malcolm, Cooke, Rosie, Hofstra, Robert ORCID: 0000-0001-7498-3829, Westers, Helga, van Wezel, Tom ORCID: 0000-0001-5773-7730, van Eijk, Ronald ORCID: 0000-0001-7955-6295, Ashworth, Alan, Rostgaard, Klaus ORCID: 0000-0001-6220-9414, Melbye, Mads, Swerdlow, Anthony J. and Houlston, Richard S. (2010). A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). Nature Genet., 42 (12). S. 1126 - 1132. NEW YORK: NATURE PUBLISHING GROUP. ISSN 1546-1718

Engert, Andreas (2016). ABVD or BEACOPP for Advanced Hodgkin Lymphoma. J. Clin. Oncol., 34 (11). S. 1167 - 1171. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Engert, Andreas (2019). First-Line Treatment of Hodgkin Lymphoma. Turk. J. Hematol., 36. S. 17 - 19. FINDIKZADE: GALENOS YAYINCILIK. ISSN 1308-5263

Engert, Andreas (2018). Treatment Algorithm for Patients with Hodgkin's Lymphoma. Onkologe, 24 (4). S. 286 - 287. NEW YORK: SPRINGER. ISSN 1433-0415

Engert, Andreas (2022). Treatment algorithm for patients with Hodgkin's lymphoma. Onkologie, 28 (10). S. 845 - 846. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 2731-7234

Engert, Andreas (2015). Treatment of advanced-stage Hodgkin lymphoma. Hematol. Oncol., 33. S. 87 - 90. HOBOKEN: WILEY. ISSN 1099-1069

Engert, Andreas (2019). Treatment of elderly Hodgkin lymphoma patients. Hematol. Oncol., 37. S. 92 - 95. HOBOKEN: WILEY. ISSN 1099-1069

Engert, Andreas, Balduini, Carlo, Brand, Anneke, Coiffier, Bertrand, Cordonnier, Catherine, Doehner, Hartmut, de Wit, Thom Duyvene, Eichinger, Sabine, Fibbe, Willem, Green, Tony, de Haas, Fleur, Iolascon, Achille, Jaffredo, Thierry, Rodeghiero, Francesco, Salles, Gilles, Schuringa, Jan Jacob, Andre, Marc, Andre-Schmutz, Isabelle ORCID: 0000-0002-3905-9910, Bacigalupo, Andrea, Bochud, Pierre-Yves ORCID: 0000-0002-2208-4757, den Boer, Monique ORCID: 0000-0002-5795-2921, Bonini, Chiara, Camaschella, Clara, Cant, Andrew, Cappellini, Maria Domenica, Cazzola, Mario, Lo Celso, Cristina, Dimopoulos, Meletios ORCID: 0000-0001-8990-3254, Douay, Luc, Dzierzak, Elaine ORCID: 0000-0001-8256-5635, Einsele, Hermann, Ferreri, Andres, De Franceschi, Lucia, Gaulard, Philippe, Gottgens, Berthold ORCID: 0000-0001-6302-5705, Greinacher, Andreas, Gresele, Paolo, Gribben, John, de Haan, Gerald ORCID: 0000-0001-9706-0138, Hansen, John-Bjarne, Hochhaus, Andreas ORCID: 0000-0003-0626-0834, Kadir, Rezan, Kaveri, Srini ORCID: 0000-0002-0837-4053, Kouskoff, Valerie, Kuehne, Thomas ORCID: 0000-0002-7387-7028, Kyrle, Paul, Ljungman, Per, Maschmeyer, Georg, Mendez-Ferrer, Simon ORCID: 0000-0002-9805-9988, Milsom, Michael, Mummery, Christine ORCID: 0000-0002-4549-6535, Ossenkoppele, Gert, Pecci, Alessandro ORCID: 0000-0001-9202-7013, Peyvandi, Flora ORCID: 0000-0001-7423-9864, Philipsen, Sjaak, Reitsma, Pieter, Maria Ribera, Jose, Risitano, Antonio, Rivella, Stefano ORCID: 0000-0002-0938-6558, Ruf, Wolfram, Schroeder, Timm ORCID: 0000-0001-9320-0252, Scully, Marie, Socie, Gerard, Staal, Frank, Stanworth, Simon, Stauder, Reinhard, Stilgenbauer, Stephan, Tamary, Hannah, Theilgaard-Monch, Kim, Thein, Swee Lay, Tilly, Herve, Trneny, Marek ORCID: 0000-0002-6952-6073, Vainchenker, William ORCID: 0000-0003-4705-202X, Vannucchi, Alessandro Maria, Viscoli, Claudio, Vrielink, Hans, Zaaijer, Hans, Zanella, Alberto, Zolla, Lello, Zwaginga, Jaap Jan, Martinez, Patricia Aguilar, van den Akker, Emile, Allard, Shubha, Anagnou, Nicholas, Andolfo, Immacolata ORCID: 0000-0003-0493-812X, Andrau, Jean-Christophe ORCID: 0000-0003-0203-8507, Angelucci, Emanuele ORCID: 0000-0002-6512-6080, Anstee, David, Aurer, Igor, Avet-Loiseau, Herve ORCID: 0000-0002-3050-0140, Aydinok, Yesim, Bakchoul, Tamam, Balduini, Alessandra, Barcellini, Wilma, Baruch, Dominique ORCID: 0000-0003-2835-5500, Baruchel, Andre, Bayry, Jagadeesh ORCID: 0000-0003-0498-9808, Bento, Celeste ORCID: 0000-0003-1080-411X, van den Berg, Anke ORCID: 0000-0002-8894-2638, Bernardi, Rosa, Bianchi, Paola ORCID: 0000-0001-5976-5233, Bigas, Anna ORCID: 0000-0003-4801-6899, Biondi, Andrea ORCID: 0000-0002-6757-6173, Bohonek, Milos, Bonnet, Dominique ORCID: 0000-0002-4735-5226, Borchmann, Peter, Borregaard, Niels, Braekkan, Sigrid ORCID: 0000-0002-9678-9696, van den Brink, Marcel, Brodin, Ellen, Bullinger, Lars, Buske, Christian, Butzeck, Barbara, Cammenga, Jorg, Campo, Elias ORCID: 0000-0001-9850-9793, Carbone, Antonino ORCID: 0000-0003-2211-639X, Cervantes, Francisco, Cesaro, Simone ORCID: 0000-0002-8698-9547, Charbord, Pierre, Claas, Frans, Cohen, Hannah, Conard, Jacqueline, Coppo, Paul, Vives Corrons, Joan-Lluis, da Costa, Lydie, Davi, Frederic, Delwel, Ruud, Dianzani, Irma, Domanovic, Dragoslav, Donnelly, Peter, Drnovsek, Tadeja Dovc, Dreyling, Martin, Du, Ming-Qing, Dufour, Carlo, Durand, Charles, Efremov, Dimitar ORCID: 0000-0001-9081-5462, Eleftheriou, Androulla, Elion, Jacques ORCID: 0000-0002-8407-1783, Emonts, Marieke, Engelhardt, Monika, Ezine, Sophie, Falkenburg, Fred, Favier, Remi, Federico, Massimo ORCID: 0000-0002-9889-3796, Fenaux, Pierre, Fitzgibbon, Jude, Flygare, Johan ORCID: 0000-0002-1962-5276, Foa, Robin, Forrester, Lesley, Galacteros, Frederic, Garagiola, Isabella, Gardiner, Chris ORCID: 0000-0002-2318-0062, Garraud, Olivier, van Geet, Christel, Geiger, Hartmut, Geissler, Jan, Germing, Ulrich, Ghevaert, Cedric, Girelli, Domenico ORCID: 0000-0001-9684-1899, Godeau, Bertrand, Goekbuget, Nicola, Goldschmidt, Hartmut, Goodeve, Anne, Graf, Thomas, Graziadei, Giovanna ORCID: 0000-0002-6801-5730, Griesshammer, Martin, Gruel, Yves, Guilhot, Francois ORCID: 0000-0001-7222-487X, von Gunten, Stephan ORCID: 0000-0002-2753-8738, Gyssens, Inge ORCID: 0000-0002-9226-0752, Halter, Jorg, Harrison, Claire, Harteveld, Cornelis, Hellstrom-Lindberg, Eva, Hermine, Olivier ORCID: 0000-0003-2574-3874, Higgs, Douglas ORCID: 0000-0003-3579-8705, Hillmen, Peter, Hirsch, Hans, Hoskin, Peter ORCID: 0000-0001-8323-9567, Huls, Gerwin, Inati, Adlette, Johnson, Peter, Kattamis, Antonis, Kiefel, Volker, Kleanthous, Marina, Klump, Hannes ORCID: 0000-0003-3536-1212, Krause, Daniela, Hovinga, Johanna Kremer, Lacaud, Georges, Lacroix-Desmazes, Sebastien ORCID: 0000-0001-5625-8447, Landman-Parker, Judith, LeGouill, Steven, Lenz, Georg, von Lilienfeld-Toal, Marie, von Lindern, Marieke ORCID: 0000-0001-6162-6320, Lopez-Guillermo, Armando, Lopriore, Enrico, Lozano, Miguel, MacIntyre, Elizabeth, Makris, Michael, Mannhalter, Christine, Martens, Joost ORCID: 0000-0003-2008-6537, Mathas, Stephan, Matzdorff, Axel, Medvinsky, Alexander, Menendez, Pablo, Migliaccio, Anna Rita, Miharada, Kenichi, Mikulska, Malgorzata, Minard, Veronique, Montalban, Carlos, de Montalembert, Mariane, Montserrat, Emili, Morange, Pierre-Emmanuel, Mountford, Joanne, Muckenthaler, Martina, Mueller-Tidow, Carsten, Mumford, Andrew, Nadel, Bertrand, Navarro, Jose-Tomas, el Nemer, Wassim, Noizat-Pirenne, France, O'Mahony, Brian, Oldenburg, Johannes, Olsson, Martin, Oostendorp, Robert, Palumbo, Antonio, Passamonti, Francesco ORCID: 0000-0001-8068-5289, Patient, Roger, de Latour, Regis Peffault, Pflumio, Francoise ORCID: 0000-0001-8995-596X, Pierelli, Luca ORCID: 0000-0002-1715-3914, Piga, Antonio, Pollard, Debra ORCID: 0000-0002-7797-3500, Raaijmakers, Marc, Radford, John, Rambach, Ralf, Rao, A. Koneti, Raslova, Hana ORCID: 0000-0001-8846-5299, Rebulla, Paolo ORCID: 0000-0002-3875-5754, Rees, David, Ribrag, Vincent, Rijneveld, Anita, Rinalducci, Sara, Robak, Tadeusz, Roberts, Irene, Rodrigues, Charlene ORCID: 0000-0003-0942-3707, Rosendaal, Frits, Rosenwald, Andreas, Rule, Simon, Russo, Roberta ORCID: 0000-0002-3624-7721, Saglio, Guiseppe, Sanchez, Mayka ORCID: 0000-0002-6499-5989, Scharf, Ruediger E., Schlenke, Peter, Semple, John, Sierra, Jorge, So-Osman, Cynthia, Manuel Soria, Jose, Stamatopoulos, Kostas, Stegmayr, Bernd, Stunnenberg, Henk, Swinkels, Dorine, Taborda Barata, Joao Pedro, Taghon, Tom, Taher, Ali, Terpos, Evangelos, Thachil, Jecko, Tissot, Jean Daniel ORCID: 0000-0003-2493-8469, Touw, Ivo, Toye, Ash, Trappe, Ralf ORCID: 0000-0001-7565-7160, Traverse-Glehen, Alexandra, Unal, Sule, Vaulont, Sophie, Viprakasit, Vip, Vitolo, Umberto, van Wijk, Richard, Wojtowicz, Agnieszka, Zeerleder, Sacha and Zieger, Barbara (2016). The European Hematology Association Roadmap for European Hematology Research: a consensus document. Haematologica, 101 (2). S. 115 - 209. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Engert, Andreas, Cerisoli, Francesco and Cools, Jan ORCID: 0000-0001-6626-5843 (2022). The Updated European Hematology Association Research Roadmap. Hemasphere, 6 (6). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 2572-9241

Engert, Andreas, Haverkamp, Heinz, Kobe, Carsten, Markova, Jana, Renner, Christoph, Ho, Anthony D., Zijlstra, Josee, Kral, Zdenek, Stein, Harald, Eich, Hans Theodor, Mueller, Rolf-Peter, Dietlein, Markus, Borchmann, Peter and Diehl, Volker (2011). Reduced Intensity of Chemotherapy and PET-Guided Radiotherapy in Patients with Advanced Stage Hodgkin Lymphoma: The GHSG HD15 Final Results. Blood, 118 (21). S. 271 - 272. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Engert, Andreas, Kobe, Carsten, Haverkamp, Heinz, Kuhnert, Georg, Markova, Jana, Lohri, Andreas, Klutmann, Susanne, Amthauer, Holger, Diehl, Volker, Borchmann, Peter and Dietlein, Markus (2012). Relative Reduction of Residual Tumor Improves Outcome Prediction of PET After Effective Chemotherapy for Patients with Advanced Stage Hodgkin Lymphoma. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Engert, Andreas and Raemaekers, John (2016). Treatment of early-stage Hodgkin lymphoma. Semin. Hematol., 53 (3). S. 165 - 171. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC. ISSN 1532-8686

Engert, Andreas, Taylor, Fiona, Bennett, Bryan, Hirji, Ishan, Cocks, Kim, McDonald, Jeffrey, Mann, Erin, Kato, Kazunobu and Cella, David (2016). Patient Subgroup Analysis of Quality-of-Life Outcomes in Checkmate 205, a Phase 2 Study of Nivolumab in Patients with Classical Hodgkin Lymphoma. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Engert, Andreas and Vassilakopoulos, Theodoros P. (2016). Hodgkin lymphoma: Introduction. Semin. Hematol., 53 (3). S. 137 - 139. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC. ISSN 1532-8686

Fanale, Michelle, Assouline, Sarit, Kuruvilla, John, Solal-Celigny, Philippe, Heo, Dae S., Verhoef, Gregor, Corradini, Paolo ORCID: 0000-0002-9186-1353, Abramson, Jeremy S., Offner, Fritz, Engert, Andreas, Dyer, Martin J. S., Carreon, Daniel, Ewald, Brett, Baeck, Johan, Younes, Anas and Freedman, Arnold S. (2014). Phase IA/II, multicentre, open-label study of the CD40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non-Hodgkin or Hodgkin lymphoma. Br. J. Haematol., 164 (2). S. 258 - 266. HOBOKEN: WILEY. ISSN 1365-2141

Felbel, Steffen, Meerpohl, Joerg J., Monsef, Ina, Engert, Andreas and Skoetz, Nicole ORCID: 0000-0003-4744-6192 (2014). Yoga in addition to standard care for patients with haematological malignancies. Cochrane Database Syst Rev. (6). HOBOKEN: WILEY. ISSN 1361-6137

Frampton, Matthew, da Silva Filho, Miguel Inacio, Broderick, Peter ORCID: 0000-0002-8348-5829, Thomsen, Hauke ORCID: 0000-0001-5951-3116, Foersti, Asta, Vijayakrishnan, Jayaram ORCID: 0000-0002-8284-2249, Cooke, Rosie, Enciso-Mora, Victor, Hoffmann, Per, Noethen, Markus M., Lloyd, Amy, Holroyd, Amy, Eisele, Lewin, Joeckel, Karl-Heinz, Ponader, Sabine, von Strandmann, Elke Pogge, Lightfoot, Tracy, Roman, Eve, Lake, Annette, Montgomery, Dorothy, Jarrett, Ruth F., Swerdlow, Anthony J., Engert, Andreas, Hemminki, Kari and Houlston, Richard S. (2013). Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma. Nat. Commun., 4. LONDON: NATURE PUBLISHING GROUP. ISSN 2041-1723

Franklin, Jeremy ORCID: 0000-0003-1536-0925, Eichenauer, Dennis A., Becker, Ingrid ORCID: 0000-0001-5829-3553, Monsef, Ina and Engert, Andreas (2017). Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis. Cochrane Database Syst Rev. (9). HOBOKEN: WILEY. ISSN 1361-6137

Freedman, Arnold S., Kuruvilla, John, Assouline, Sarit E., Engert, Andreas, Heo, DaeSeog, Solal-Celigny, Philippe, Corradini, Paolo, Verhoef, Gregor, Fanale, Michelle A., Bendiske, Jennifer, Ewald, Brett, Dey, Jyotirmoy, Baeck, Johan and Younes, Anas (2010). Clinical Activity of Lucatumumab (HCD122) In Patients (pts) with Relapsed/Refractory Hodgkin or Non-Hodgkin Lymphoma Treated In a Phase Ia/II Clinical Trial (NCT00670592). Blood, 116 (21). S. 129 - 130. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Fuchs, Michael, Goergen, Helen, Kobe, Carsten, Borchmann, Peter and Engert, Andreas (2020). Inability of Fluorodeoxyglucose Positron Emission Tomography to Detect Viable Hodgkin Lymphoma During and After Treatment Reply. J. Clin. Oncol., 38 (10). S. 1116 - 1119. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Fuchs, Michael, Goergen, Helen, Kobe, Carsten, Eich, Hans, Baues, Christian, Greil, Richard, Sasse, Stephanie, Zijlstra, Josee M., Lohri, Andreas, Rosenwald, Andreas, von Tresckow, Bastian, Diehl, Volker, Kuhnert, Georg, Dietlein, Markus, Borchmann, Peter and Engert, Andreas (2018). PET-Guided Treatment of Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase 3 Trial HD16 By the German Hodgkin Study Group. Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Fuchs, Michael, Goergen, Helen, Kobe, Carsten, Kuhnert, Georg, Lohri, Andreas, Greil, Richard, Sasse, Stephanie, Topp, Max S., Schaefer, Erhardt, Hertenstein, Bernd, Soekler, Martin, Vogelhuber, Martin, Zijlstra, Josee M., Keller, Ulrich Bernd, Krause, Stefan W., Wilhelm, Martin, Maschmeyer, Georg, Thiemer, Julia, Duehrsen, Ulrich, Meissner, Julia, Viardot, Andreas, Eich, Hans, Baues, Christian, Diehl, Volker, Rosenwald, Andreas, von Tresckow, Bastian, Dietlein, Markus, Borchmann, Peter and Engert, Andreas (2019). Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group. J. Clin. Oncol., 37 (31). S. 2835 - 2847. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Gandhi, Mitul D., Evens, Andrew M., Fenske, Timothy S., Hamlin, Paul, Coiffier, Bertrand, Engert, Andreas, Moskowitz, Alison J., Ghosh, Nilanjan, Petrich, Adam M., Lomasney, Jon, Chadburn, Amy, Wood, Gary S., Salva, Katrin, Nardone, Beatrice ORCID: 0000-0003-1509-3791, Trifilio, Steven M., Raisch, Dennis W., West, Dennis P., Gordon, Leo I. and Winter, Jane N. (2014). Pancreatitis in patients treated with brentuximab vedotin: a previously unrecognized serious adverse event. Blood, 123 (18). S. 2895 - 2898. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Garcia-Marquez, Maria A., Thelen, Martin ORCID: 0000-0002-2785-9726, Reinke, Sarah, Keller, Diandra, Wennhold, Kerstin, Lehmann, Jonas, Veldman, Johanna ORCID: 0000-0003-4253-0870, Borchmann, Sven ORCID: 0000-0001-6662-6864, Rosenwald, Andreas, Sasse, Stephanie, Diepstra, Arjan ORCID: 0000-0001-9239-1050, Borchmann, Peter, Engert, Andreas, Klapper, Wolfram, Von Bergwelt-Baildon, Michael, Broeckelmann, Paul J. and Schloesser, Hans A. (2022). Reverted exhaustion phenotype of circulating lymphocytes as immune correlate of anti-PD1 first-line treatment in Hodgkin lymphoma. Leukemia, 36 (3). S. 760 - 772. LONDON: SPRINGERNATURE. ISSN 1476-5551

Gerhard-Hartmann, Elena ORCID: 0000-0003-2134-2774, Goergen, Helen, Broeckelmann, Paul J., Mottok, Anja, Steinmueller, Tabea ORCID: 0000-0001-7099-1223, Grund, Johanna, Zamo, Alberto, Ben-Neriah, Susana, Sasse, Stephanie, Borchmann, Sven ORCID: 0000-0001-6662-6864, Fuchs, Michael, Borchmann, Peter, Reinke, Sarah, Engert, Andreas, Veldman, Johanna ORCID: 0000-0003-4253-0870, Diepstra, Arjan ORCID: 0000-0001-9239-1050, Klapper, Wolfram and Rosenwald, Andreas (2022). 9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trial. Br. J. Haematol., 196 (1). S. 116 - 127. HOBOKEN: WILEY. ISSN 1365-2141

Gillessen, Sarah, Huettmann, Andreas, Vucinic, Vladan, Mueller, Horst, Pluetschow, Annette, Viardot, Andreas, Topp, Max S., Kobe, Carsten, Boell, Boris, Eichenauer, Dennis A. ORCID: 0000-0002-1927-3514, Sasse, Stephanie, Haverkamp, Heinz, Schmitz, Christine, Borchmann, Sven, Broeckelmann, Paul J., Heger, Jan-Michel, Fushs, Michael, Engert, Andreas, Borchmann, Peter and von Tresckow, Bastian (2022). Reinduction therapy with everolimus in combination with dexamethasone, high-dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: an experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD-R3i). Br. J. Haematol., 196 (3). S. 606 - 617. HOBOKEN: WILEY. ISSN 1365-2141

Gillessen, Sarah, Kobe, Carsten, Engert, Andreas and von Tresckow, Bastian (2020). PET positivity - the agony of choice: response assessment and interpretation of increased FDG uptake of residual mediastinal tissue after frontline therapy in Hodgkin lymphoma. Leuk. Lymphoma, 61 (2). S. 251 - 255. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Gillessen, Sarah, Pluetschow, Annette, Vucinic, Vladan ORCID: 0000-0002-8398-285X, Ostermann, Helmut, Kobe, Carsten, Broeckelmann, Paul J., Boell, Boris, Eichenauer, Dennis A., Heger, Jan-Michel ORCID: 0000-0001-9463-8504, Borchmann, Sven, Fuchs, Michael, Borchmann, Peter, Engert, Andreas and von Tresckow, Bastian (2022). JAK inhibition with ruxolitinib in relapsed or refractory classical Hodgkin lymphoma: Final results of a phase II, open label, multicentre clinical trial (JeRiCHO). Eur. J. Haematol., 109 (6). S. 728 - 736. HOBOKEN: WILEY. ISSN 1600-0609

Goldkuhle, Marius, Dimaki, Maria, Gartlehner, Gerald ORCID: 0000-0001-5531-3678, Monsef, Ina, Dahm, Philipp, Glossmann, Jan-Peter, Engert, Andreas, von Tresckow, Bastian and Skoetz, Nicole (2018). Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer). Cochrane Database Syst Rev. (7). HOBOKEN: WILEY. ISSN 1361-6137

Gopal, Ajay K., Chen, Robert, Smith, Scott E., Ansell, Stephen M., Rosenblatt, Joseph D., Savage, Kerry J., Connors, Joseph M., Engert, Andreas, Larsen, Emily K., Chi, Xuedong, Sievers, Eric L. and Younes, Anas (2015). Durable remissions in a pivotal phase 2 study of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma. Blood, 125 (8). S. 1236 - 1244. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Gopal, Ajay K., Chen, Robert, Smith, Scott E., Ansell, Stephen M., Rosenblatt, Joseph D., Savage, Kerry J., Connors, Joseph M., Engert, Andreas, Larsen, Emily K., Chi, Xuedong, Sievers, Eric L. and Younes, Anas (2015). Durable remissions in a pivotal phase 2 study of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma. Blood, 125 (8). S. 1236 - 1244. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Gopal, Ajay K., Pro, Barbara, Connors, Joseph M., Younes, Anas, Engert, Andreas, Shustov, Andrei R., Chi, Xuedong, Larsen, Emily K., Kennedy, Dana A. and Sievers, Eric L. (2016). Response assessment in lymphoma: Concordance between independent central review and local evaluation in a clinical trial setting. Clin. Trials, 13 (5). S. 545 - 555. LONDON: SAGE PUBLICATIONS LTD. ISSN 1740-7753

Green, Tony, Bron, Dominique, Chomienne, Christine, de Wit, Thom Duyvene, de Haas, Fleur, Engert, Andreas, Hagenbeek, Anton, Jaeger, Ulrich, MacIntyre, Elizabeth, Muckenthaler, Martina U., Smand, Carin and Sonneveld, Pieter (2016). Costs of haematological disease high and rising. Lancet Haematol., 3 (8). S. E353 - 2. OXFORD: ELSEVIER SCI LTD. ISSN 2352-3026

Halbsguth, Teresa V., Nogova, Lucia, Mueller, Horst, Sieniawski, Michal, Eichenauer, Dennis A., Schober, Thomas, Nisters-Backes, Hiltrud, Borchmann, Peter, Diehl, Volker, Engert, Andreas and Josting, Andreas (2010). Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG). Blood, 116 (12). S. 2026 - 2033. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Hansen, Hinrich P., Engels, Hanna-Mareike, Dams, Maria, Paes Leme, Adriana F., Pauletti, Bianca Alves, Simhadri, Vijaya Lakshmi, Duerkop, Horst, Reiners, Katrin S., Barnert, Sabine, Engert, Andreas, Schubert, Rolf, Quondamatteo, Fabio, Hallek, Michael and von Strandmann, Elke Pogge (2014). Protrusion-guided extracellular vesicles mediate CD30 trans-signalling in the microenvironment of Hodgkin's lymphoma. J. Pathol., 232 (4). S. 405 - 415. HOBOKEN: WILEY. ISSN 1096-9896

Hansen, Hinrich P., Trad, Ahmad, Dams, Maria, Zigrino, Paola ORCID: 0000-0002-7470-0064, Moss, Marcia, Tator, Maximilian, Schoen, Gisela, Grenzi, Patricia C., Bachurski, Daniel ORCID: 0000-0001-9168-9680, Aquino, Bruno, Duerkop, Horst, Reiners, Katrin S., von Bergwelt-Baildon, Michael, Hallek, Michael, Groetzinger, Joachim, Engert, Andreas, Paes Leme, Adriana F. and von Strandmann, Elke Pogge (2016). CD30 on extracellular vesicles from malignant Hodgkin cells supports damaging of CD30 ligand-expressing bystander cells with Brentuximab-Vedotin, in vitro. Oncotarget, 7 (21). S. 30523 - 30536. ORCHARD PARK: IMPACT JOURNALS LLC. ISSN 1949-2553

Harrison, Simon J., Hsu, Andy K., Neeson, Paul ORCID: 0000-0002-2729-5887, Younes, Anas, Sureda, Anna, Engert, Andreas, Prince, H. Miles, Li, Martha, Savage, Paula, Bugarini, Roberto, Williams, Denise, Squier, Margaret and Ritchie, David S. (2014). Early thymus and activation-regulated chemokine (TARC) reduction and response following panobinostat treatment in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplant. Leuk. Lymphoma, 55 (5). S. 1053 - 1061. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Hartmann, Sylvia, Eichenauer, Dennis A., Pluetschow, Annette, Mottok, Anja ORCID: 0000-0003-3125-0494, Bob, Roshanak, Koch, Karoline, Bernd, Heinz-Wolfram, Cogliatti, Sergio, Hummel, Michael, Feller, Alfred C., Ott, German, Moeller, Peter, Rosenwald, Andreas, Stein, Harald, Hansmann, Martin-Leo, Engert, Andreas and Klapper, Wolfram (2014). Histopathological features and their prognostic impact in nodular lymphocyte-predominant Hodgkin lymphoma - a matched pair analysis from the German Hodgkin Study Group (GHSG). Br. J. Haematol., 167 (2). S. 238 - 243. HOBOKEN: WILEY-BLACKWELL. ISSN 1365-2141

Hartmann, Sylvia, Eichenauer, Dennis A., Pluetschow, Annette, Mottok, Anja ORCID: 0000-0003-3125-0494, Bob, Roshanak, Koch, Karoline, Bernd, Heinz-Wolfram, Cogliatti, Sergio, Hummel, Michael, Feller, Alfred C., Ott, German, Moeller, Peter, Rosenwald, Andreas, Stein, Harald, Hansmann, Martin-Leo, Engert, Andreas and Klapper, Wolfram (2013). The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG). Blood, 122 (26). S. 4246 - 4253. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Hartmann, Sylvia, Pluetschow, Annette, Mottok, Anja, Bernd, Heinz-Wolfram, Feller, Alfred C., Ott, German, Cogliatti, Sergio, Fend, Falko, Quintanilla-Martinez, Leticia, Stein, Harald, Klapper, Wolfram, Moeller, Peter, Rosenwald, Andreas, Engert, Andreas, Hansmann, Martin-Leo and Eichenauer, Dennis A. (2019). The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphoma. Am. J. Hematol., 94 (11). S. 1208 - 1214. HOBOKEN: WILEY. ISSN 1096-8652

Hartmann, Sylvia, Soltani, Ahmad Sajad, Bankov, Katrin ORCID: 0009-0005-4033-4966, Bein, Julia, Hansmann, Martin-Leo, Rosenwald, Andreas, Bernd, Heinz-Wolfram, Feller, Alfred, Ott, German, Moeller, Peter, Stein, Harald, Klapper, Wolfram, Borchmann, Peter, Engert, Andreas and Eichenauer, Dennis A. (2022). Tumour cell characteristics and microenvironment composition correspond to clinical presentation in newly diagnosed nodular lymphocyte-predominant Hodgkin lymphoma. Br. J. Haematol., 199 (3). S. 382 - 392. HOBOKEN: WILEY. ISSN 1365-2141

Hartmann, Tim, Huebel, Kai, Monsef, Ina, Engert, Andreas and Skoetz, Nicole (2015). Additional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in people with malignant lymphoma or multiple myeloma. Cochrane Database Syst Rev. (10). HOBOKEN: WILEY. ISSN 1361-6137

Haverkamp, Heinz ORCID: 0000-0001-6895-4132, Boell, Boris, Eichenauer, Dennis A., Sasse, Stephanie, Fuchs, Michael, Borchmann, Peter, Diehl, Volker, Engert, Andreas and von Tresckow, Bastian (2015). Impact of Bleomycin and Vincristine Dose Reductions in Patients With Advanced Hodgkin Lymphoma Treated With BEACOPP: An Analysis of the German Hodgkin Study Group HD12 and HD15 Trials. J. Clin. Oncol., 33 (22). S. 2430 - 2440. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Hentrich, Marcus, Berger, Marcel, Wyen, Christoph, Siehl, Jan, Rockstroh, Juergen K., Mueller, Markus, Faetkenheuer, Gerd, Seidel, Elisabeth, Nickelsen, Maike, Wolf, Timo, Rieke, Ansgar, Schuermann, Dirk, Schmidmaier, Ralf, Planker, Manfred, Alt, Juergen, Mosthaf, Franz, Engert, Andreas, Arasteh, Keikawus and Hoffmann, Christian (2012). Stage-Adapted Treatment of HIV-Associated Hodgkin Lymphoma: Results of a Prospective Multicenter Study. J. Clin. Oncol., 30 (33). S. 4117 - 4124. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Hohloch, Karin, Zwick, Carsten, Ziepert, Marita, Hasenclever, Dirk, Kaiser, Ulrich, Engert, Andreas, Hoeffkes, Heinz-Gert, Kroschinsky, Frank, Mesters, Rolf, Feller, Andreas C., Loeffler, Markus, Truemper, Lorenz and Pfreundschuh, Michael (2014). Significant dose Escalation of Idarubicin in the treatment of aggressive Non- Hodgkin Lymphoma leads to increased hematotoxicity without improvement in efficacy in comparison to standard CHOEP-14: 9-year follow up results of the CIVEP trial of the DSHNHL. SpringerPlus, 3. CHAM: SPRINGER INTERNATIONAL PUBLISHING AG. ISSN 2193-1801

Hude, Ida, Sasse, Stephanie, Broeckelmann, Paul J., von Tresckow, Bastian, Momotow, Jesko, Engert, Andreas and Borchmann, Sven (2018). Leucocyte and eosinophil counts predict progression-free survival in relapsed or refractory classical Hodgkin Lymphoma patients treated with PD1 inhibition. Br. J. Haematol., 181 (6). S. 837 - 841. HOBOKEN: WILEY. ISSN 1365-2141

Hude, Ida, Sasse, Stephanie, Engert, Andreas and Broeckelmann, Paul J. (2017). The emerging role of immune checkpoint inhibition in malignant lymphoma. Haematologica, 102 (1). S. 30 - 43. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Hutzschenreuter, Franz, Monsef, Ina, Kreuzer, Karl-Anton, Engert, Andreas and Skoetz, Nicole (2016). Granulocyte and granulocyte-macrophage colony stimulating factors for newly diagnosed patients with myelodysplastic syndromes. Cochrane Database Syst Rev. (2). HOBOKEN: WILEY. ISSN 1361-6137

Jachimowicz, Ron D. and Engert, Andreas (2014). The Challenging Aspects of Managing Adolescents and Young Adults with Hodgkin's Lymphoma. Acta Haematol., 132 (3-4). S. 274 - 279. BASEL: KARGER. ISSN 1421-9662

Jachimowicz, Ron D., Klapper, Wolfram, Glehr, Gunther ORCID: 0000-0002-1495-9162, Mueller, Horst, Haverkamp, Heinz, Thorns, Christoph, Hansmann, Martin Leo, Moeller, Peter, Stein, Harald, Rehberg, Thorsten, von Tresckow, Bastian, Reinhardt, H. C., Borchmann, Peter, Chan, Fong Chun, Spang, Rainer, Scott, David W., Engert, Andreas, Steidl, Christian, Altenbuchinger, Michael and Rosenwald, Andreas (2021). Gene expression-based outcome prediction in advanced stage classical Hodgkin lymphoma treated with BEACOPP. Leukemia, 35 (12). S. 3589 - 3594. LONDON: SPRINGERNATURE. ISSN 1476-5551

Jachimowicz, Ron Daniel, Pieper, Luise, Reinke, Sarah, Gontarewicz, Artur, Pluetschow, Annette, Haverkamp, Heinz, Frauenfeld, Leonie, Fend, Falko, Overkamp, Mathis, Jochims, Franziska, Thorns, Christoph, Hansmann, Martin Leo, Moller, Peter, Rosenwald, Andreas, Stein, Harald, Reinhardt, Hans Christian, Borchmann, Peter, von Tresckow, Bastian, Engert, Andreas and Klapper, Wolfram (2021). Whole-slide image analysis of the tumor as a predictor of adverse outcome in patients with advanced-stage classical Hodgkin lymphoma treated with BEACOPP. Haematologica, 106 (6). S. 1684 - 1693. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Jacob, Anne Sophie, Kaul, Helen, Fuchs, Michael, Gillessen, Sarah, Kreissl, Stefanie, Pluetschow, Annette, Momotow, Jesko, Schaub, Valdete, Huettmann, Andreas, Haenel, Mathias, Zimmermann, Andreas, Dierlamm, Judith, Meissner, Julia, Mathas, Stephan, Martin, Sonja, Engert, Andreas, Hallek, Michael ORCID: 0000-0002-7425-4455, Borchmann, Peter and Lehmann, Clara (2022). Impact of the first COVID-19 lockdown in Germany on the rate of acute infections during intensive chemotherapy for Hodgkin lymphoma. Infection, 50 (4). S. 925 - 933. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-0973

Jakob, Carolin E. M., Classen, Annika Y., Stecher, Melanie, Engert, Andreas, Freund, Meike, Hamprecht, Axel ORCID: 0000-0003-1449-5780, Jazmati, Nathalie, Wisplinghoff, Hilmar, Hallek, Michael, Cornely, Oliver A. and Vehreschild, Joerg J. (2021). Association between the dietary regimen and infection-related complications in neutropenic high-risk patients with cancer. Eur. J. Cancer, 155. S. 281 - 291. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852

Josting, Andreas, Mueller, Horst, Borchmann, Peter, Baars, Joke W., Metzner, Bernd ORCID: 0000-0002-1496-1377, Doehner, Hartmut, Aurer, Igor, Smardova, Lenka, Fischer, Thomas, Niederwieser, Dietger, Schaefer-Eckart, Kerstin, Schmitz, Norbert, Sureda, Anna, Glossmann, Jan, Diehl, Volker, DeJong, Daphne, Hansmann, Martin-Leo, Raemaekers, John and Engert, Andreas (2010). Dose Intensity of Chemotherapy in Patients With Relapsed Hodgkin's Lymphoma. J. Clin. Oncol., 28 (34). S. 5074 - 5081. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Karuturi, Meghan S., Arai, Sally, Chen, Robert W., Gopal, Ajay K., Feng, Lei, Yuan, Ying, Smith, Scott E., Ansell, Stephen M., Rosenblatt, Joseph D., Savage, Kerry J., Ramchandren, Radhakrishnan, Bartlet, Nancy L., Cheson, Bruce D., Forero-Torres, Andres, Moskowitz, Craig H., Connors, Joseph M., Fanale, Michelle A., de Vos, Sven, Engert, Andreas, Illidge, Tim, Borchmann, Peter, Morschhauser, Franck, Horning, Sandra J. and Younes, Anas (2012). Overall Survival Benefit for Patients with Relapsed Hodgkin Lymphoma Treated with Brentuximab Vedotin After Autologous Stem Cell Transplant. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Kim, Austin, Engert, Andreas, Gorgen, Helen, Maranda, Louise, LaCasce, Ann S. and Borchmann, Sven (2016). Suicide in European Hodgkin Lymphoma Patients. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Kim, Austin, I, Goergen, Helen, Engert, Andreas, LaCasce, Ann S., Maranda, Louise, Barton, Bruce and Borchmann, Sven (2019). Suicide in European Hodgkin Lymphoma Patients. Hemasphere, 3 (2). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 2572-9241

Klein, Jan M., Henke, Alexander, Sauer, Maike, Bessler, Martina, Reiners, Katrin S., Engert, Andreas, Hansen, Hinrich P. and von Strandmann, Elke Pogge (2013). The Histone Deacetylase Inhibitor LBH589 (Panobinostat) Modulates the Crosstalk of Lymphocytes with Hodgkin Lymphoma Cell Lines. PLoS One, 8 (11). SAN FRANCISCO: PUBLIC LIBRARY SCIENCE. ISSN 1932-6203

Klimm, Beate, Brillant, Corinne, Skoetz, Nicole ORCID: 0000-0003-4744-6192, Mueller, Horst, Engert, Andreas and Borchmann, Peter (2012). The Effect of Specialized Cancer Treatment Centers on Treatment Efficacy in Hodgkin's Lymphoma. Dtsch. Arztebl. Int., 109 (51-52). S. 893 - 900. COLOGNE: DEUTSCHER AERZTE-VERLAG GMBH. ISSN 1866-0452

Klimm, Beate, Franklin, Jeremy ORCID: 0000-0003-1536-0925, Stein, Harald, Eichenauer, Dennis A., Haverkamp, Heinz ORCID: 0000-0001-6895-4132, Diehl, Volker, Fuchs, Michael, Borchmann, Peter and Engert, Andreas (2011). Lymphocyte-Depleted Classical Hodgkin's Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group. J. Clin. Oncol., 29 (29). S. 3914 - 3921. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Klimm, Beate, Goergen, Helen, Fuchs, Michael, von Tresckow, Bastian, Diehl, Volker, Eich, Hans Theodor, Engert, Andreas and Borchmann, Peter (2012). Discrimination of an Early Unfavorable Risk Group Has Significant Impact On Treatment Outcome in Early-Stage Hodgkin Lymphoma: An Analysis of International Staging Definitions and Risk Factors. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Kobe, Carsten, Goergen, Helen, Baues, Christian, Kuhnert, Georg, Voltin, Conrad-Amadeus ORCID: 0000-0002-5437-3959, Zijlstra, Josee, Hoekstra, Otto, Mettler, Jasmin, Drzezga, Alexander, Engert, Andreas, Borchmann, Peter and Dietlein, Markus (2018). Outcome-based interpretation of early interim PET in advanced-stage Hodgkin lymphoma. Blood, 132 (21). S. 2273 - 2280. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Kobe, Carsten, Kuhnert, Georg, Kahraman, Deniz, Haverkamp, Heinz ORCID: 0000-0001-6895-4132, Eich, Hans-Theodor, Franke, Mareike, Persigehl, Thorsten, Klutmann, Susanne, Amthauer, Holger, Bockisch, Andreas, Kluge, Regine, Wolf, Hans-Heinrich, Maintz, David, Fuchs, Michael, Borchmann, Peter, Diehl, Volker, Drzezga, Alexander, Engert, Andreas and Dietlein, Markus (2014). Assessment of Tumor Size Reduction Improves Outcome Prediction of Positron Emission Tomography/Computed Tomography After Chemotherapy in Advanced-Stage Hodgkin Lymphoma. J. Clin. Oncol., 32 (17). S. 1776 - 1782. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Kobe, Carsten, Voltin, Conrad-Amadeus, Baues, Christian, Fuchs, Michael, Dietlein, Markus, Engert, Andreas, Borchmann, Peter and Drzezga, Alexander (2017). Staging Hodgkin Lymphoma Using PET - Can We Safely Exclude Bone Marrow Involvement? J. Nucl. Med., 58. RESTON: SOC NUCLEAR MEDICINE INC. ISSN 1535-5667

Kreissl, Stefanie, Goergen, Helen, Mueller, Horst, Meissner, Julia, Mehnert, Anja, Buerkle, Carolin, Fuchs, Michael, Engert, Andreas, Behringer, Karolin and Borchmann, Peter (2019). Survivors' perspectives on risks and benefits of Hodgkin lymphoma treatment: results of a survey by the German Hodgkin Study Group. Leuk. Lymphoma, 60 (6). S. 1389 - 1399. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Kreissl, Stefanie, Goergen, Helen, von Tresckow, Bastian, Behringer, Karolin, Markova, Jana, Lohri, Andreas, Meissner, Julia, Zijlstra, Josee M., Greil, Richard, Topp, Max S., Soekler, Martin, Doehner, Hartmut, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2015). Primary Progressive Disease in Hodgkin Lymphoma Patients: A Retrospective Analysis from the German Hodgkin Study Group. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Kreissl, Stefanie, Mueller, Horst, Goergen, Helen, Mayer, Axel, Brillant, Corinne, Behringer, Karolin, Halbsguth, Teresa Veronika, Hitz, Felicitas, Soekler, Martin, Shonukan, Oluwatoyin, Rueffer, Jens Ulrich, Flechtner, Hans-Henning, Fuchs, Michael, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2016). Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study Group. Lancet Oncol., 17 (10). S. 1453 - 1463. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488

Kreissl, Stefanie, Mueller, Horst, Goergen, Helen, Meissner, Julia, Topp, Max, Soekler, Martin, Markova, Jana, Bernhard, Jurg, Greil, Richard, von Tresckow, Bastian, Behringer, Karolin, Rueffer, Jens-Ulrich, Flechtner, Hans-Henning, Moestl, Michaela, Fuchs, Michael, Engert, Andreas, Diehl, Volker and Borchmann, Peter (2020). Health-Related Quality of Life in Patients With Hodgkin Lymphoma: A Longitudinal Analysis of the German Hodgkin Study Group. J. Clin. Oncol., 38 (25). S. 2839 - 2857. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Kreissl, Stefanie, Mueller, Horst, Mayer, Axel, Behringer, Karolin, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2014). Fatigue in Hodgkin Lymphoma Patients: Longitudinal Evaluation and Curve Types up to 5 Years. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Kreissl, Stefanie, Voltin, Conrad-Amadeus ORCID: 0000-0002-5437-3959, Kaul, Helen, Buehnen, Ina, Mettler, Jasmin, Pabst, Thomas, Eichenauer, Dennis A. ORCID: 0000-0002-1927-3514, Fuchs, Michael, Diehl, Volker, Dietlein, Markus, Engert, Andreas, Borchmann, Peter and Kobe, Carsten . Impact of bone marrow involvement on early positron emission tomography response and progression-free survival in the HD18 trial for patients with advanced-stage Hodgkin lymphoma. Br. J. Haematol.. HOBOKEN: WILEY. ISSN 1365-2141

Kreissl, Stefanie, von Tresckow, Bastian, Goergen, Helen, Haverkamp, Heinz, Sasse, Stephanie, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2016). Beacoppescalated Followed By Radiotherapy of Initial Bulk or Residual Disease in Advanced Stage Hodgkin Lymphoma: Long-Term Follow up of the HD9 and HD12 Trials of the German Hodgkin Study Group. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Kremer, Andreas E., van Dijk, Remco, Leckie, Pamela, Schaap, Frank G., Kuiper, Edith M. M., Mettang, Thomas, Reiners, Katrin S., Raap, Ulrike, van Buuren, Henk R., van Erpecum, Karel J., Davies, Nathan A., Rust, Christian, Engert, Andreas, Jalan, Rajiv, Elferink, Ronald P. J. Oude and Beuers, Ulrich (2012). Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions. Hepatology, 56 (4). S. 1391 - 1401. HOBOKEN: WILEY. ISSN 1527-3350

Kueppers, Ralf, Engert, Andreas and Hansmann, Martin-Leo (2012). Hodgkin lymphoma. J. Clin. Invest., 122 (10). S. 3439 - 3448. ANN ARBOR: AMER SOC CLINICAL INVESTIGATION INC. ISSN 1558-8238

Law, Philip J., Sud, Amit ORCID: 0000-0002-6133-0164, Mitchell, Jonathan S., Henrion, Marc ORCID: 0000-0003-1242-839X, Orlando, Giulia, Lenive, Oleg, Broderick, Peter, Speedy, Helen E., Johnson, David C., Kaiser, Martin, Weinhold, Niels, Cooke, Rosie, Sunter, Nicola J., Jackson, Graham H., Summerfield, Geoffrey, Harris, Robert J., Pettitt, Andrew R., Allsup, David J., Carmichael, Jonathan, Bailey, James R., Pratt, Guy, Rahman, Thahira, Pepper, Chris, Fegan, Chris, von Strandmann, Elke Pogge, Engert, Andreas, Foersti, Asta, Chen, Bowang, da Silva Filho, Miguel Inacio, Thomsen, Hauke ORCID: 0000-0001-5951-3116, Hoffmann, Per, Noethen, Markus M., Eisele, Lewin, Joeckel, Karl-Heinz, Allan, James M., Swerdlow, Anthony J., Goldschmidt, Hartmut, Catovsky, Daniel, Morgan, Gareth J., Hemminki, Kari and Houlston, Richard S. (2017). Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci. Sci Rep, 7. LONDON: NATURE PUBLISHING GROUP. ISSN 2045-2322

Lohr, Frank ORCID: 0000-0003-1014-5556, Georg, Dietmar ORCID: 0000-0002-8327-3877, Cozzi, Luca, Eich, Hans Theodor, Weber, Damien C., Koeck, Julia, Knausl, Barbara ORCID: 0000-0003-4031-1711, Dieckmann, Karin, Abo-Madyan, Yasser ORCID: 0000-0003-2205-503X, Fiandra, Christian, Mueller, Rolf-Peter, Engert, Andreas and Ricardi, Umberto (2014). Novel radiotherapy techniques for involved-field and involved-node treatment of mediastinal Hodgkin lymphoma When should they be considered and which questions remain open? Strahlenther. Onkol., 190 (10). S. 864 - 871. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-099X

Mettler, Jasmin, Mueller, Horst, Voltin, Conrad-Amadeus ORCID: 0000-0002-5437-3959, Baues, Christian, Klaeser, Bernd, Moccia, Alden, Borchmann, Peter, Engert, Andreas, Kuhnert, Georg, Drzezga, Alexander, Dietlein, Markus and Kobe, Carsten (2019). Metabolic Tumor Volume for Response Prediction in Advanced-Stage Hodgkin Lymphoma. J. Nucl. Med., 60 (2). S. 207 - 212. RESTON: SOC NUCLEAR MEDICINE INC. ISSN 1535-5667

Momotow, Jesko, Borchmann, Sven ORCID: 0000-0001-6662-6864, Eichenauer, Dennis A., Engert, Andreas and Sasse, Stephanie (2021). Hodgkin Lymphoma-Review on Pathogenesis, Diagnosis, Current and Future Treatment Approaches for Adult Patients. J. Clin. Med., 10 (5). BASEL: MDPI. ISSN 2077-0383

Momotow, Jesko, Buehnen, Ina, Trautmann-Grill, Karolin, Kobbe, Guido, Hahn, Dennis, Schroers, Roland ORCID: 0000-0003-2744-5491, Heinrich, Bernhard, Gaska, Tobias, Forstbauer, Helmut, Schmidt, Burkhard, Boger, Regina, Huettmann, Andreas, Heil, Gerhard, Kraemer, Doris M., Krueger, William, Zeremski, Vanja, Grobe, Norbert, Jentsch-Ullrich, Kathleen, Griesinger, Frank, Fuchs, Michael, von Tresckow, Bastian, Borchmann, Peter, Engert, Andreas and Broeckelmann, Paul J. (2022). Outcomes of anti-programmed death 1 treatment for relapsed/refractory Hodgkin lymphoma: A German Hodgkin Study Group multicentre real-world analysis. Br. J. Haematol., 198 (2). S. 401 - 405. HOBOKEN: WILEY. ISSN 1365-2141

Rancea, Michaela, Engert, Andreas, Borchmann, Peter, von Tresckow, Bastian, Halbsguth, Teresa, Behringer, Karolin, Wongso, Diana, Boell, Boris, Klimm, Beate, Thielen, Indra, Eichenauer, Dennis A. and Skoetz, Nicole (2012). Interdisciplinary Evidence-Based Guideline for Diagnosis, Therapy and Follow-up of Adult Hodgkin Lymphoma Patients. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Rancea, Michaela, Will, Andrea, Borchmann, Peter, Monsef, Ina, Engert, Andreas and Skoetz, Nicole ORCID: 0000-0003-4744-6192 (2014). Sixteenth Biannual Report of the Cochrane Haematological Malignancies Group: Focus on Non-Hodgkin's Lymphoma. JNCI-J. Natl. Cancer Inst., 106 (8). CARY: OXFORD UNIV PRESS INC. ISSN 1460-2105

Rancea, Michaela, von Tresckow, Bastian, Monsef, Ina, Engert, Andreas and Skoetz, Nicole ORCID: 0000-0003-4744-6192 (2014). High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed or refractory Hodgkin lymphoma: A systematic review with meta-analysis. Crit. Rev. Oncol./Hematol., 92 (1). S. 1 - 11. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1879-0461

Reinke, Sarah, Broeckelmann, Paul J., Iaccarino, Ingram, Garcia-Marquez, Maria, Borchmann, Sven, Jochims, Franziska, Kotrova, Michaela ORCID: 0000-0001-5394-1072, Pal, Karol, Brueggemann, Monika, Hartmann, Elena, Sasse, Stephanie, Kobe, Carsten, Mathas, Stephan, Soekler, Martin, Keller, Ulrich, Bormann, Matthias, Zimmermann, Andreas, Richter, Julia, Fuchs, Michael, von Tresckow, Bastian, Borchmann, Peter, Schloesser, Hans, von Bergwelt-Baildon, Michael, Rosenwald, Andreas, Engert, Andreas and Klapper, Wolfram (2020). Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1. Blood, 136 (25). S. 2851 - 2864. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Roemer, Margaretha G. M., Ligon, Azra H., Engert, Andreas, Younes, Anas, Santoro, Armando, Zinzani, Pier Luigi, Timmerman, John M., Ansell, Stephen, Armand, Philippe, Fanale, Michelle A., Ratanatharathorn, Voravit, Kuruvilla, John, Cohen, Jonathon B., Collins, Graham P., Savage, Kerry J., Trneny, Marek, Neuberg, Donna S., Redd, Robert A., Farsaci, Benedetto ORCID: 0000-0001-8275-2561, Kato, Kazunobu, Sumbul, Anne, Rodig, Scott J. and Shipp, Margaret A. (2016). Chromosome 9p24.1/PD-L1/PD-L2Alterations and PD-L1 Expression and Treatment Outcomes in Patients with Classical Hodgkin Lymphoma Treated with Nivolumab (PD-1 Blockade). Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Rosenbrock, Johannes, Vasquez-Torres, Andres, Mueller, Horst, Behringer, Karolin, Zerth, Matthias, Celik, Eren, Fan, Jiaqi, Trommer, Maike, Linde, Philipp, Fuchs, Michael, Borchmann, Peter, Engert, Andreas, Marnitz, Simone and Baues, Christian (2021). Involved Site Radiotherapy Extends Time to Premature Menopause in Infra-Diaphragmatic Female Hodgkin Lymphoma Patients - An Analysis of GHSG HD14-and HD17-Patients. Front. Oncol., 11. LAUSANNE: FRONTIERS MEDIA SA. ISSN 2234-943X

Rothe, Achim, Jachimowicz, Ron D., Borchmann, Sven, Madlener, Marie, Kessler, Joerg, Reiners, Katrin S., Sauer, Maike, Hansen, Hinrich P., Ullrich, Roland T., Chatterjee, Sampurna, Borchmann, Peter, Yazaki, Paul, Koslowsky, Thomas C., Engert, Andreas, Heukamp, Lukas C., Hallek, Michael and von Strandmann, Elke Pogge (2014). The bispecific immunoligand ULBP2-aCEA redirects natural killer cells to tumor cells and reveals potent anti-tumor activity against colon carcinoma. Int. J. Cancer, 134 (12). S. 2829 - 2841. HOBOKEN: WILEY. ISSN 1097-0215

Rothe, Achim, Reiners, Katrin S., Topp, Max S., Younes, Anas, von Tresckow, Bastian, Hummel, Horst Dieter, Kessler, Joerg, Ravic, Miroslav, Marschner, Jens-Peter, von Strandmann, Elke Pogge and Engert, Andreas (2014). AFM13: an antigen specific immunotherapy for the treatment of CD30+malignancies: Results of first-in-man study in relapsed/refractory (R/R) Hodgkin lymphoma (HL). Cancer Res., 74 (19). PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445

Rothe, Achim, Sasse, Stephanie, Goergen, Helen, Eichenauer, Dennis A., Lohri, Andreas, Jaeger, Ulrich, Bangard, Christopher and Engert, Andreas (2012). Brentuximab Vedotin (SGN-35) in Patients with Relapsed/Refractory CD30-Positive Hematologic Malignancies without Prior High-Dose Chemotherapy and Stem Cell Transplantation. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Rothe, Achim, Sasse, Stephanie, Topp, Max S., Eichenauer, Dennis A., Hummel, Horst, Reiners, Katrin S., Dietlein, Markus, Kuhnert, Georg, Kessler, Joerg, Buerkle, Carolin, Ravic, Miroslav, Knackmuss, Stefan, Marschner, Jens-Peter, von Strandmann, Elke Pogge, Borchmann, Peter and Engert, Andreas (2015). A phase 1 study of the bispecific anti-CD30/CD16A antibody construct AFM13 in patients with relapsed or refractory Hodgkin lymphoma. Blood, 125 (26). S. 4024 - 4032. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Rothe, Achim, Sasse, Stephanie, Topp, Max S., Eichenauer, Dennis A., von Tresckow, Bastian, Hummel, Horst-Dieter, Ravic, Miroslav, Marschner, Jens-Peter and Engert, Andreas (2014). Specific NK Cell Activation to Treat Relapsed/Refractory (r/r) Hodgkin Lymphoma (HL) Patients - Final, Updated Data on Clinical Outcome, Pharmacokinetics and Pharmacodynamics of a Phase 1 Study Investigating AFM13, a Bispecific Anti-CD30/CD16A Tandab. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Rothe, Achim, Topp, Max S., Eichenauer, Dennis A., von Tnasckow, Bastian, Hummel, Horst-Dieter, Ravic, Miroslav, Marschner, Jens-Peter and Engert, Andreas (2014). Updated phase I data of AFM13: A bispecific tandem antibody (TandAb) in relapsed/refractory (R/R) Hodgkin lymphoma (HL). J. Clin. Oncol., 32 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Rothe, Achim, Younes, Anas, Reiners, Katrin S., Dietlein, Markus, Eichenauer, Dennis A., Kessler, Joerg, Topp, Max S., Hummel, Horst, Ravic, Miroslav, Hucke, Christian, von Strandmann, Elke Pogge and Engert, Andreas (2011). A Phase I Study with the Bispecific Anti-CD30 x Anti-CD16A Antibody Construct AFM13 in Patients with Relapsed or Refractory Hodgkin Lymphoma. Blood, 118 (21). S. 1585 - 1586. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Sasse, Stephanie, Alram, Magdalena, Mueller, Horst, Smardova, Lenka, Metzner, Bernd, Doehner, Hartmut, Fischer, Thomas, Niederwieser, Dietger W., Schmitz, Norbert, Schaefer-Eckart, Kerstin, Raemaekers, John M. M., Schmalz, Oliver, Tresckow, Bastian V., Engert, Andreas and Borchmann, Peter (2016). Prognostic relevance of DHAP dose-density in relapsed Hodgkin lymphoma: an analysis of the German Hodgkin-Study Group. Leuk. Lymphoma, 57 (5). S. 1067 - 1074. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Sasse, Stephanie, Brockelmann, Paul Jan, Momotow, Jesko, Plutschow, Annette, Huttmann, Andreas, Basara, Nadezda, Koenecke, Christian, Martin, Sonja, Bentz, Martin, Grosse-Thie, Christina, Thorspecken, Sven, de Wit, Maike, Kobe, Carsten, Dietlein, Markus, v Tresckow, Bastian, Fuchs, Michael, Borchmann, Peter and Engert, Andreas (2022). AFM13 in patients with relapsed or refractory classical Hodgkin lymphoma: final results of an open-label, randomized, multicenter phase II trial. Leuk. Lymphoma, 63 (8). S. 1871 - 1879. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Sasse, Stephanie, Broeckelmann, Paul J., Goergen, Helen, Pluetschow, Annette, Mueller, Horst, Kreissl, Stefanie, Buerkle, Carolin, Borchmann, Sven, Fuchs, Michael, Borchmann, Peter, Diehl, Volker and Engert, Andreas (2017). Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials. J. Clin. Oncol., 35 (18). S. 1999 - 2009. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Sasse, Stephanie, Goergen, Helen, Pluetschow, Annette, Boell, Boris, Eichenauer, Dennis A., Fuchs, Michael, Behringer, Karolin, Zijlstra, Josee M., Greil, Richard, Markova, Jana, Topp, Max S., Meissner, Julia, Neubauer, Andreas, Baues, Christian, Engert, Andreas, Borchmann, Peter and von Tresckow, Bastian (2018). Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group. J. Clin. Oncol., 36 (25). S. 2603 - 2621. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Sasse, Stephanie, Rothe, Achim, Goergen, Helen, Eichenauer, Dennis A., Lohri, Andreas, Kreher, Stephan, Jaeger, Ulrich, Bangard, Christopher, Kuhnert, Georg, Boell, Boris, von Tresckow, Bastian and Engert, Andreas (2013). Brentuximab vedotin (SGN-35) in patients with transplant-naive relapsed/refractory Hodgkin lymphoma. Leuk. Lymphoma, 54 (10). S. 2144 - 2149. LONDON: INFORMA HEALTHCARE. ISSN 1042-8194

Sauer, Maike, Reiners, Katrin S., Hansen, Hinrich P., Engert, Andreas, Gasser, Stephan ORCID: 0000-0002-5616-0914 and von Strandmann, Elke Pogge (2013). Induction of the DNA damage response by IAP inhibition triggers natural immunity via upregulation of NKG2D ligands in Hodgkin lymphoma in vitro. Biol. Chem., 394 (10). S. 1325 - 1332. BERLIN: WALTER DE GRUYTER GMBH. ISSN 1437-4315

Schmidt, Amand F., Holmes, Michael V., Preiss, David, Swerdlow, Daniel I., Denaxas, Spiros ORCID: 0000-0001-9612-7791, Fatemifar, Ghazaleh, Faraway, Rupert, Finan, Chris, Valentine, Dennis, Fairhurst-Hunter, Zammy, Hartwig, Fernando Pires, Horta, Bernardo Lessa, Hypponen, Elina ORCID: 0000-0003-3670-9399, Power, Christine, Moldovan, Max ORCID: 0000-0001-9680-8474, van Iperen, Erik, Hovingh, Kees, Demuth, Ilja, Norman, Kristina ORCID: 0000-0003-2029-9102, Steinhagen-Thiessen, Elisabeth, Demuth, Juri, Bertram, Lars, Lill, Christina M., Coassin, Stefan ORCID: 0000-0001-5677-8979, Willeit, Johann, Kiechl, Stefan, Willeit, Karin, Mason, Dan, Wright, John, Morris, Richard, Wanamethee, Goya, Whincup, Peter, Ben-Shlomo, Yoav, McLachlan, Stela, Price, Jackie F., Kivimaki, Mika, Welch, Catherine, Sanchez-Galvez, Adelaida, Marques-Vidal, Pedro ORCID: 0000-0002-4548-8500, Nicolaides, Andrew, Panayiotou, Andrie G., Onland-Moret, N. Charlotte, van der Schouw, Yvonne T., Matullo, Giuseppe, Fiorito, Giovanni, Guarrera, Simonetta, Sacerdote, Carlotta, Wareham, Nicholas J., Langenberg, Claudia, Scott, Robert A., Luan, Jian'an, Bobak, Martin, Malyutina, Sofia, Pajak, Andrzej, Kubinova, Ruzena, Tamosiunas, Abdonas, Pikhart, Hynek ORCID: 0000-0001-5277-4049, Grarup, Niels ORCID: 0000-0001-5526-1070, Pedersen, Oluf ORCID: 0000-0002-3321-3972, Hansen, Torben ORCID: 0000-0001-8748-3831, Linneberg, Allan ORCID: 0000-0002-0994-0184, Jess, Tine, Cooper, Jackie, Humphries, Steve E., Brilliant, Murray, Kitchner, Terrie, Hakonarson, Hakon, Carrell, David S., McCarty, Catherine A., Lester, Kirchner H., Larson, Eric B., Crosslin, David R., de Andrade, Mariza, Roden, Dan M., Denny, Joshua C., Carty, Cara, Hancock, Stephen, Attia, John, Holliday, Elizabeth, Scott, Rodney, Schofield, Peter ORCID: 0000-0001-8298-8590, O'Donnell, Martin ORCID: 0000-0002-7347-7761, Yusuf, Salim, Chong, Michael, Pare, Guillaume, van der Harst, Pim, Said, M. Abdullah ORCID: 0000-0003-2920-7745, Eppinga, Ruben N., Verweij, Niek, Snieder, Harold, Christen, Tim, Mook-Kanamori, D. O., Gustafsson, Stefan, Lind, Lars, Ingelsson, Erik, Pazoki, Raha, Franco, Oscar, Hofman, Albert, Uitterlinden, Andre, Dehghan, Abbas, Teumer, Alexander ORCID: 0000-0002-8309-094X, Baumeister, Sebastian, Doerr, Marcus, Lerch, Markus M. ORCID: 0000-0002-9643-8263, Voelker, Uwe, Voelzke, Henry, Ward, Joey, Pell, Jill P., Meade, Tom, Christophersen, Ingrid E., Maitland-van der Zee, Anke H., Baranova, Ekaterina V., Young, Robin, Ford, Ian, Campbell, Archie, Padmanabhan, Sandosh, Bots, Michiel L., Grobbee, Diederick E., Froguel, Philippe, Thuillier, Dorothee, Roussel, Ronan, Bonnefond, Amelie, Cariou, Bertrand, Smart, Melissa, Bao, Yanchun, Kumari, Meena, Mahajan, Anubha, Hopewell, Jemma C., Seshadri, Sudha ORCID: 0000-0001-6135-2622, Dale, Caroline, Costa, Rui Providencia E., Ridker, Paul M., Chasman, Daniel I., Reiner, Alex P., Ritchie, Marylyn D., Lange, Leslie A., Cornish, Alex J., Dobbins, Sara E., Hemminki, Kari, Kinnersley, Ben, Sanson, Marc, Labreche, Karim, Simon, Matthias, Bondy, Melissa, Law, Philip, Speedy, Helen, Allan, James, Li, Ni, Went, Molly, Weinhold, Niels, Morgan, Gareth, Sonneveld, Pieter, Nilsson, Bjorn, Goldschmidt, Hartmut, Sud, Amit ORCID: 0000-0002-6133-0164, Engert, Andreas, Hansson, Markus, Hemingway, Harry, Asselbergs, Folkert W., Patel, Riyaz S., Keating, Brendan J., Sattar, Naveed, Houlston, Richard, Casas, Juan P. and Hingorani, Aroon D. (2019). Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9. BMC Cardiovasc. Disord., 19 (1). LONDON: BMC. ISSN 1471-2261

Sickinger, Marie T., von Tresckow, Bastian, Kobe, Carsten, Borchmann, Peter, Engert, Andreas and Skoetz, Nicole (2016). PET-adapted omission of radiotherapy in early stage Hodgkin lymphoma-a systematic review and meta-analysis. Crit. Rev. Oncol./Hematol., 101. S. 86 - 93. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1879-0461

Sickinger, Marie-Therese, von Tresckow, Bastian, Kobe, Carsten, Engert, Andreas, Borchmann, Peter and Skoetz, Nicole (2015). Positron emission tomography-adapted therapy for first-line treatment in individuals with Hodgkin lymphoma. Cochrane Database Syst Rev. (1). HOBOKEN: WILEY. ISSN 1361-6137

Skoetz, Nicole, Bohlius, Julia ORCID: 0000-0003-1955-1585, Engert, Andreas, Monsef, Ina, Blank, Oliver and Vehreschild, Joerg-Janne (2015). Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy. Cochrane Database Syst Rev. (12). HOBOKEN: WILEY. ISSN 1361-6137

Skoetz, Nicole, Will, Andrea, Monsef, Ina, Brillant, Corinne, Engert, Andreas and von Tresckow, Bastian (2017). Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma. Cochrane Database Syst Rev. (5). HOBOKEN: WILEY. ISSN 1361-6137

Sud, Amit ORCID: 0000-0002-6133-0164, Thomsen, Hauke ORCID: 0000-0001-5951-3116, Law, Philip J., Foersti, Asta, da Silva Filho, Miguel Inacio, Holroyd, Amy, Broderick, Peter ORCID: 0000-0002-8348-5829, Orlando, Giulia, Lenive, Oleg, Wright, Lauren, Cooke, Rosie, Easton, Douglas, Pharoah, Paul ORCID: 0000-0001-8494-732X, Dunning, Alison, Peto, Julian, Canzian, Federico ORCID: 0000-0002-4261-4583, Eeles, Rosalind ORCID: 0000-0002-3698-6241, Kote-Jarai, ZSofia, Muir, Kenneth, Pashayan, Nora ORCID: 0000-0003-0843-2468, Hoffmann, Per, Noethen, Markus M., Joeckel, Karl-Heinz, von Strandmann, Elke Pogge, Lightfoot, Tracy, Kane, Eleanor, Roman, Eve, Lake, Annette, Montgomery, Dorothy, Jarrett, Ruth F., Swerdlow, Anthony J., Engert, Andreas, Orr, Nick, Hemminki, Kari and Houlston, Richard S. (2017). Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility. Nat. Commun., 8. LONDON: NATURE PUBLISHING GROUP. ISSN 2041-1723

Sud, Amit ORCID: 0000-0002-6133-0164, Thomsen, Hauke ORCID: 0000-0001-5951-3116, Orlando, Giulia, Foersti, Asta, Law, Philip J., Broderick, Peter ORCID: 0000-0002-8348-5829, Cooke, Rosie, Hariri, Fadi, Pastinen, Tomi, Easton, Douglas F., Pharoah, Paul D. P., Dunning, Alison M., Peto, Julian, Canzian, Federico ORCID: 0000-0002-4261-4583, Eeles, Rosalind ORCID: 0000-0002-3698-6241, Kote-Jarai, ZSofia, Muir, Kenneth, Pashayan, Nora, Campa, Daniele, Hoffmann, Per, Noethen, Markus M., Joeckel, Karl-Heinz, von Strandmann, Elke Pogge, Swerdlow, Anthony J., Engert, Andreas, Orr, Nick, Hemminki, Kari and Houlston, Richard S. (2018). Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphoma. Blood, 132 (19). S. 2040 - 2053. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Sureda, Anna, Younes, Anas, Ben-Yehuda, Dina, Ong, Tee-Chuan, Kaufman, Jonathan L., Le Corre, Christophe, Gallagher, Jennifer, Shen, Angela and Engert, Andreas (2010). Final Analysis: Phase II Study of Oral Panobinostat In Relapsed/Refractory Hodgkin Lymphoma Patients Following Autologous Hematopoietic Stem Cell Transplant. Blood, 116 (21). S. 187 - 188. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Theurich, Sebastian, Malcher, Joke, Wennhold, Kerstin, Shimabukuro-Vornhagen, Alexander, Chemnitz, Jens M., Udo, Holtick, Krause, Anke, Kobe, Carsten, Kahraman, Deniz, Geothy, Chakupurakal, Engert, Andreas, Christof, Scheid, Hallek, Michael and von Bergwelt-Baildon, Michael (2012). CD30-Targeted Therapy with Brentuximab Vedotin Combined with Donor Lymphocyte Infusions Induce Sustained Clinical Remissions and Tumor Specific Immunity in a Series of Patients with Relapsed Hodgkin Lymphoma After Allogeneic Stem Cell Transplantation. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Thomsen, Hauke ORCID: 0000-0001-5951-3116, da Silva Filho, Miguel Inacio, Fuchs, Michael, Ponader, Sabine, von Strandmann, Elke Pogge, Eisele, Lewin, Herms, Stefan ORCID: 0000-0002-2786-8200, Hoffmann, Per, Engert, Andreas, Hemminki, Kari and Forsti, Asta (2016). Evidence of Inbreeding in Hodgkin Lymphoma. PLoS One, 11 (4). SAN FRANCISCO: PUBLIC LIBRARY SCIENCE. ISSN 1932-6203

Thurner, Lorenz, Hartmann, Sylvia, Fadle, Natalie, Regitz, Evi, Kemele, Maria, Kim, Yoo-Jin, Bohle, Rainer Maria, Nimmesgern, Anna, von Mueller, Lutz, Kempf, Volkhard A. J., Weniger, Marc A., Neumann, Frank, Schneider, Nadine, Vornanen, Martine, Sundstrom, Christer, de Leval, Laurence, Engert, Andreas, Eichenauer, Dennis A., Kueppers, Ralf, Preuss, Klaus-Dieter, Hansmann, Martin-Leo and Pfreundschuh, Michael (2020). Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphoma. Nat. Commun., 11 (1). LONDON: NATURE PUBLISHING GROUP. ISSN 2041-1723

Timmerman, John M., Engert, Andreas, Younes, Anas, Santoro, Armando, Armand, Philippe, Fanale, Michelle A., Collins, Graham P., Ratanatharathorn, Voravit, Kuruvilla, John, Cohen, Jonathon B., Savage, Kerry J., Trneny, Marek, De Boer, Jan Paul, Shipp, Margaret A., Rodig, Scott J., Kato, Kazunobu, Sumbul, Anne and Ansell, Stephen (2016). Checkmate 205 Update with Minimum 12-Month Follow up: A Phase 2 Study of Nivolumab in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Ullrich, Katrin, Wurster, Kathrin D., Lamprecht, Bjoern, Koechert, Karl, Engert, Andreas, Doerken, Bernd, Janz, Martin ORCID: 0000-0002-1127-0044 and Mathas, Stephan (2011). BAY 43-9006/Sorafenib blocks CSF1R activity and induces apoptosis in various classical Hodgkin lymphoma cell lines. Br. J. Haematol., 155 (3). S. 398 - 404. HOBOKEN: WILEY. ISSN 1365-2141

Voltin, Conrad-Amadeus ORCID: 0000-0002-5437-3959, Mettler, Jasmin, van Heek, Lutz, Goergen, Helen, Mueller, Horst, Baues, Christian, Keller, Ulrich, Meissner, Julia, Trautmann-Grill, Karolin, Kerkhoff, Andrea, Fuchs, Michael, Sasse, Stephanie, von Tresckow, Bastian, Dietlein, Markus, Borchmann, Peter, Engert, Andreas, Kobe, Carsten and Broeckelmann, Paul J. (2021). Early Response to First-Line Anti-PD-1 Treatment in Hodgkin Lymphoma: A PET-Based Analysis from the Prospective, Randomized Phase II NIVAHL Trial. Clin. Cancer Res., 27 (2). S. 402 - 408. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1557-3265

Walewski, Jan ORCID: 0000-0003-4247-2674, Hellmann, Andrzej, Siritanaratkul, Noppadol, Ozsan, Guner Hayri, Ozcan, Muhit, Chuncharunee, Suporn, Goh, Ai Sim, Jurczak, Wojciech ORCID: 0000-0003-1879-8084, Koren, Jan, Paszkiewicz-Kozik, Ewa, Wang, Bingxia, Singh, Shalini, Huebner, Dirk, Engert, Andreas and von Tresckow, Bastian (2018). Prospective study of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma patients who are not suitable for stem cell transplant or multi-agent chemotherapy. Br. J. Haematol., 183 (3). S. 400 - 411. HOBOKEN: WILEY. ISSN 1365-2141

Younes, Anas, Santoro, Armando ORCID: 0000-0003-1709-9492, Shipp, Margaret, Zinzani, Pier Luigi, Timmerman, John M., Ansell, Stephen, Armand, Philippe, Fanale, Michelle, Ratanatharathorn, Voravit, Kuruvilla, John, Cohen, Jonathon B., Collins, Graham ORCID: 0000-0002-8803-4234, Savage, Kerry J., Trneny, Marek ORCID: 0000-0002-6952-6073, Kato, Kazunobu, Farsaci, Benedetto ORCID: 0000-0001-8275-2561, Parker, Susan M., Rodig, Scott, Roemer, Margaretha G. M., Ligon, Azra H. and Engert, Andreas (2016). Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial. Lancet Oncol., 17 (9). S. 1283 - 1295. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488

Younes, Anas, Santoro, Armando, Zinzani, Pier Luigi, Timmerman, John, Ansell, Stephen Maxted, Armand, Philippe, Fanale, Michelle A., Ratanatharathorn, Voravit, Kuruvilla, John, Cohen, Jonathon Brett, Collins, Graham P., Savage, Kerry J., Trneny, Marek, Kato, Kazunobu, Farsaci, Benedetto ORCID: 0000-0001-8275-2561, Parker, Susan M., Rodig, Scott J., Shipp, Margaret Ann and Engert, Andreas (2016). Checkmate 205: Nivolumab (nivo) in classical Hodgkin lymphoma (cHL) after autologous stem cell transplant (ASCT) and brentuximab vedotin (BV) A phase 2 study. J. Clin. Oncol., 34 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Younes, Anas, Sehn, Laurie H., Johnson, Peter ORCID: 0000-0003-2306-4974, Zinzani, Pier Luigi, Hong, Xiaonan, Zhu, Jun, Patti, Caterina, Belada, David ORCID: 0000-0002-4981-6188, Samoilova, Olga, Suh, Cheolwon, Leppae, Sirpa, Rai, Shinya, Turgut, Mehmet, Jurczak, Wojciech ORCID: 0000-0003-1879-8084, Cheung, Matthew C., Gurion, Ronit, Yeh, Su-Peng, Lopez-Hernandez, Andres, Duehrsen, Ulrich, Thieblemont, Catherine, Chiattone, Carlos Sergio, Balasubramanian, Sriram, Carey, Jodi, Liu, Grace, Shreeve, S. Martin, Sun, Steven, Zhuang, Sen Hong, Vermeulen, Jessica, Staudt, Louis M., Wilson, Wyndham, Fisher, Richard I., Engert, Andreas, Stadtmauer, Edward A. and Wei, Lee-Jen (2019). Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma. J. Clin. Oncol., 37 (15). S. 1285 - 1307. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Zacher, Jonas ORCID: 0000-0002-9687-5746, Kasenda, Benjamin ORCID: 0000-0003-0110-8585, Engert, Andreas and Skoetz, Nicole ORCID: 0000-0003-4744-6192 (2014). The role of additional radiotherapy for primary central nervous system lymphoma. Cochrane Database Syst Rev. (6). HOBOKEN: WILEY. ISSN 1361-6137

van Heek, Lutz, Stuka, Colin, Kaul, Helen, Mueller, Horst, Mettler, Jasmin, Hitz, Felicitas, Baues, Christian, Fuchs, Michael, Borchmann, Peter, Engert, Andreas, Dietlein, Markus, Voltin, Conrad-Amadeus and Kobe, Carsten (2022). Predictive value of baseline metabolic tumor volume in early-stage favorable Hodgkin Lymphoma - Data from the prospective, multicenter phase III HD16 trial. BMC Cancer, 22 (1). LONDON: BMC. ISSN 1471-2407

von Tresckow, Bastian, Boell, Boris, Eichenauer, Dennis, Beschorner, Denissa, Knop, Stefan, Goebeler, Maria-Elisabeth, Chemnitz, Jens Marcus, Hallek, Michael, Engert, Andreas and Huebel, Kai (2014). Anti-epidermal growth factor receptor antibody cetuximab in refractory or relapsed multiple myeloma: a phase II prospective clinical trial. Leuk. Lymphoma, 55 (3). S. 695 - 698. LONDON: INFORMA HEALTHCARE. ISSN 1029-2403

von Tresckow, Bastian and Engert, Andreas (2013). Refractory Hodgkin Lymphoma. Curr. Opin. Oncol., 25 (5). S. 463 - 470. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1531-703X

von Tresckow, Bastian and Engert, Andreas (2011). The Role of Autologous Transplantation in Hodgkin Lymphoma. Curr. Hematol. Malig. Rep., 6 (3). S. 172 - 180. PHILADELPHIA: CURRENT MEDICINE GROUP. ISSN 1558-822X

von Tresckow, Bastian and Engert, Andreas (2012). The emerging role of PET in Hodgkin lymphoma patients receiving autologous stem cell transplant. Expert Rev. Hematol., 5 (5). S. 483 - 487. LONDON: EXPERT REVIEWS. ISSN 1747-4086

von Tresckow, Bastian, Gundermann, Stefan, Eichenauer, Dennis A., Aulitzky, Walter Erich, Goebeler, Mariele, Sayehli, Cyrus, Bacchus, Liza, Hauns, Bernhard, Mais, Anna, Hentsch, Bernd, Kohihof, Hella, Krauss, Rolf, Krauss, Babett, Baumgartner, Roland, Vitt, Daniel and Engert, Andreas (2014). First-in-human study of 4SC-202, a novel oral HDAC inhibitor in advanced hematologic malignancies (TOPAS study). J. Clin. Oncol., 32 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

von Tresckow, Bastian, Huettmann, Andreas, Vucinic, Vladan, Mueller, Horst, Pluetschow, Annette, Viardot, Andreas, Topp, Max S., Kobe, Carsten, Boell, Boris, Eichenauer, Dennis A., Sasse, Stephanie, Haverkamp, Heinz, Fuchs, Michael, Engert, Andreas and Borchmann, Peter (2018). Induction Therapy with Everolimus in Combination with DHAP (Dexamethasone, High-Dose AraC, Cisplatinum) in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma: A Randomized, Placebo-Controlled Phase I/II Trial (HD-R3i). Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

von Tresckow, Bastian, Kreissl, Stefanie, Goergen, Helen, Brockelmann, Paul J., Pabst, Thomas, Fridrik, Michael, Rummel, Mathias, Jung, Wolfram, Thiemer, Julia, Sasse, Stephanie, Burkle, Carolin, Baues, Christian, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2018). Intensive treatment strategies in advanced-stage Hodgkin's lymphoma (HD9 and HD12): analysis of long-term survival in two randomised trials. Lancet Haematol., 5 (10). S. E462 - 12. OXFORD: ELSEVIER SCI LTD. ISSN 2352-3026

von Tresckow, Bastian, Morschhauser, Franck, Szer, Jeffrey, Eichenauer, Dennis A., Abramson, Jeremy S., Sureda, Anna and Engert, Andreas (2017). Panobinostat consolidation in patients with Hodgkin lymphoma at risk for relapse after high dose chemotherapy and autologous stem cell transplant: final results after early trial discontinuation. Leuk. Lymphoma, 58 (1). S. 222 - 226. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

von Tresckow, Bastian, Mueller, Horst, Eichenauer, Dennis A., Glossmann, Jan P., Josting, Andreas, Boell, Boris, Klimm, Beate, Sasse, Stephanie, Fuchs, Michael, Borchmann, Peter and Engert, Andreas (2014). Outcome and risk factors of patients with Hodgkin Lymphoma who relapse or progress after autologous stem cell transplant. Leuk. Lymphoma, 55 (8). S. 1922 - 1925. LONDON: INFORMA HEALTHCARE. ISSN 1029-2403

von Tresckow, Bastian, Pluetschow, Annette, Haverkamp, Heinz, Vucinic, Vladan, Rank, Andreas, Topp, Max S., Feuring-Buske, Michaela, Kobe, Carsten, Kuhnert, Georg, Boell, Boris, Eichenauer, Dennis A., Sasse, Stephanie, Fuchs, Michael, Engert, Andreas and Borchmann, Peter (2014). A Phase I Study of Everolimus in Combination with Time-Intensified DHAP ( Dexamethasone, High-Dose AraC [Cytarabine], Cisplatinum) in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma (cHL). Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

von Tresckow, Bastian, Sayehli, Cyrus, Aulitzky, Walter E., Goebeler, Maria-Elisabeth, Schwab, Matthias, Braz, Eunice, Krauss, Babett, Krauss, Rolf, Hermann, Frank, Bartz, Rene and Engert, Andreas (2019). Phase I study of domatinostat (4SC-202), a class I histone deacetylase inhibitor in patients with advanced hematological malignancies. Eur. J. Haematol., 102 (2). S. 163 - 174. HOBOKEN: WILEY. ISSN 1600-0609